[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 317
1. Sambhaji CJ, Chauhan A, Kakkar C: Inflammatory myofibroblastic tumor mimics an abdominal neoplasm. Gastrointest Cancer Res; 2009 Nov;3(6):254-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inflammatory myofibroblastic tumor mimics an abdominal neoplasm.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21151431.001).
  • [ISSN] 1934-7987
  • [Journal-full-title] Gastrointestinal cancer research : GCR
  • [ISO-abbreviation] Gastrointest Cancer Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3000074
  •  go-up   go-down


2. Jakob J, Moesta KT, Rau B: [Increasing abdominal pain caused by abdominal tumor in a 21-year-old female]. Chirurg; 2005 Feb;76(2):175-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Increasing abdominal pain caused by abdominal tumor in a 21-year-old female].
  • We present a case of mesenteric cystic lymphangioma in a young woman who was admitted to hospital with a history of increasing abdominal pain.
  • We discuss diagnostic means, differential diagnosis, and therapeutic management of the disease.
  • [MeSH-major] Abdominal Pain / etiology. Lymphangioma, Cystic. Mesentery. Peritoneal Neoplasms
  • [MeSH-minor] Adult. Biopsy. Diagnosis, Differential. Female. Humans. Laparoscopy. Radiography, Abdominal. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Abdominal Pain.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Pediatr Surg. 2002 Feb;12(1):13-8 [11967753.001]
  • [Cites] J Pediatr Surg. 1998 Nov;33(11):1599-604 [9856875.001]
  • [Cites] J Pediatr Surg. 1999 Jul;34(7):1164-8 [10442614.001]
  • [Cites] Langenbecks Arch Chir Suppl Kongressbd. 1998;115:399-404 [9931649.001]
  • [Cites] J Pediatr Surg. 1992 Feb;27(2):220-4; discussion 224-6 [1564622.001]
  • [Cites] Arch Surg. 1985 Nov;120(11):1266-9 [4051731.001]
  • [Cites] Surgery. 2003 Mar;133(3):238-42 [12660633.001]
  • [Cites] J Am Coll Surg. 2003 Apr;196(4):598-603 [12691938.001]
  • [Cites] Chirurg. 2001 Jan;72 (1):72-7 [11225460.001]
  • [Cites] Chirurg. 1995 Mar;66(3):229-31 [7750397.001]
  • (PMID = 15551011.001).
  • [ISSN] 0009-4722
  • [Journal-full-title] Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
  • [ISO-abbreviation] Chirurg
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


3. Iwamoto I, Yanazume S, Fujino T, Yoshioka T, Douchi T: Leydig cell tumor in an elderly patient with complete androgen insensitivity syndrome. Gynecol Oncol; 2005 Mar;96(3):870-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leydig cell tumor in an elderly patient with complete androgen insensitivity syndrome.
  • Testicular tumors often develop in patients with AIS, Sertoli cell tumor and seminoma being the most common types.
  • Leydig cell tumor in AIS is extremely rare.
  • CASE: A large abdominal tumor developed in a 73-year-old female patient.
  • The patient underwent the extirpation of bilateral gonads including the tumor, pelvic lymph nodes, omentum and appendix vermiformis.
  • The pathological diagnosis was malignant Leydig cell tumor of the left testis.
  • The patient showed no evidence of disease at the post-operative 1 month checkup.
  • CONCLUSION: We reported an extremely rare case of malignant Leydig cell tumor developing in an elderly AIS patient.
  • [MeSH-major] Androgen-Insensitivity Syndrome / complications. Leydig Cell Tumor / complications. Ovarian Neoplasms / complications


Advertisement
4. da Costa e Silva EJ, da Silva GA: Eliminating unenhanced CT when evaluating abdominal neoplasms in children. AJR Am J Roentgenol; 2007 Nov;189(5):1211-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Eliminating unenhanced CT when evaluating abdominal neoplasms in children.
  • OBJECTIVE: The purpose of our study was to evaluate a CT protocol that eliminates the unenhanced phase for imaging pediatric abdominal neoplasms.
  • MATERIALS AND METHODS: We retrospectively performed a case series study of all the abdominal CT scans on children and adolescents found in our archives.
  • The radiologists were separately asked to formulate the most probable diagnosis and to decide whether tumor calcification was present.
  • The sensitivity and specificity of each method for diagnosing the more frequent neoplasms were also measured.
  • The sensitivity and specificity of the two methods for the most frequent neoplasms were similar.
  • The evaluations without the unenhanced phase showed good sensitivity and specificity for tumor calcifications.
  • CONCLUSION: CT protocols without the unenhanced phase are a viable alternative for evaluating abdominal neoplasms in children and adolescents.
  • [MeSH-major] Abdominal Neoplasms / radiography. Image Enhancement / methods. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17954663.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Nakaoka T, Uemura S, Nakagawa Y, Yano T, Oda M: Retroperitoneal ganglioneuroblastoma resected 8 years after mass screening: a case report. J Pediatr Surg; 2007 Nov;42(11):E29-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An 8-year-old girl presented with abdominal tumor that was discovered incidentally.
  • At surgery, the tumor originated from the retroperitoneal sympathetic trunk; and the histologic diagnosis was ganglioneuroblastoma, nodular (GNBn), unfavorable histology on Shimada's classification, International Neuroblastoma Staging System (INSS) stage 1.
  • There was no tumor detected, and tumor markers decreased to normal range by 18 months of age.
  • We examined her previous computed tomographic films retrospectively and noticed a mass in the same region indicating that the tumor had been there for 8 years without treatment.
  • [MeSH-major] Biomarkers, Tumor / blood. Ganglioneuroblastoma / diagnosis. Retroperitoneal Neoplasms / diagnosis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18022424.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


6. Cissé M, Konaté I, Dieng M, Ka O, Dia A, Touré CT: [Giant leiomyoma of fallopian tube: a rare aetiology of abdominal tumor]. J Gynecol Obstet Biol Reprod (Paris); 2008 Dec;37(8):799-801
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Giant leiomyoma of fallopian tube: a rare aetiology of abdominal tumor].
  • [Transliterated title] Léiomyome géant de la trompe utérine: une cause rare de tumeur abdominale.
  • We report a revealed case by a voluminous-abdominal mass in a 35-year-old woman.
  • Neither the tomodensitometry nor, even, the laparoscopy did not permit specifying the tubal origin of the tumor.
  • [MeSH-major] Fallopian Tube Neoplasms / diagnosis. Leiomyoma / diagnosis
  • [MeSH-minor] Abdomen. Adult. Diagnosis, Differential. Female. Humans. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18805654.001).
  • [ISSN] 0368-2315
  • [Journal-full-title] Journal de gynécologie, obstétrique et biologie de la reproduction
  • [ISO-abbreviation] J Gynecol Obstet Biol Reprod (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


7. An JY, Heo JS, Noh JH, Sohn TS, Nam SJ, Choi SH, Joh JW, Kim SJ: Primary malignant retroperitoneal tumors: analysis of a single institutional experience. Eur J Surg Oncol; 2007 Apr;33(3):376-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary malignant retroperitoneal tumors: analysis of a single institutional experience.
  • AIMS: In order to achieve complete resection in the surgical management of retroperitoneal tumors, it is crucial to know the tumor's anatomical location relative to neighboring organs.
  • METHODS: Forty-nine patients with primary malignant retroperitoneal tumors were divided by tumor location into two groups [upper abdomen (group 1) or lower abdomen (group 2)], and clinicopathological features, tumor recurrence, and patient survival were assessed.
  • RESULTS: No significant differences in preoperative clinical characteristics existed between two groups, and liposarcoma was the most frequently observed tumor type.
  • The 5-year survival rate of patients with tumors smaller than 10 cm was 78.4%, while that of patients with tumors larger than 10 cm was 38.1% (p=0.017).
  • CONCLUSIONS: An upper abdominal tumor location is a positive prognostic factor even if small tumor size (<10 cm) and complete resection of the tumor are still more important factors to improve outcome in patients with malignant primary retroperitoneal tumors.
  • Because complete resection was shown to be the most important prognostic factor, an aggressive and careful surgical approach is recommended for the treatment of such tumors.
  • [MeSH-major] Liposarcoma / surgery. Retroperitoneal Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Chi-Square Distribution. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Proportional Hazards Models. Survival Rate. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17129700.001).
  • [ISSN] 0748-7983
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


8. Gomes AL, Freitas Filho LG, Leão JQ, Heinisch AC, Carnevale J: Ectopic opening of the vas deferens into a Müllerian duct cyst. J Pediatr Urol; 2007 Apr;3(2):151-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ectopic opening of the vas deferens into Müllerian duct cysts is a rare entity but should always be considered when a child presents with purulent urinary discharge and abdominal tumor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18947723.001).
  • [ISSN] 1873-4898
  • [Journal-full-title] Journal of pediatric urology
  • [ISO-abbreviation] J Pediatr Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


9. Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM: Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer; 2008 Dec 1;123(11):2658-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among those known, most presented with abdominal (56%, M:F 1.4:1) vs. only facial tumors (35%, M:F 3.0:1).
  • Abdominal tumors occurred in older (mean age: 7.0 vs. 6.0 years; p < 0.001) and more frequently in female children (68% vs. 50%; OR 2.2, 95% CI 1.5-3.5).
  • Jaw tumors were characterized by young age and male gender, but presentation has shifted away from facial to mostly abdominal.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • [Cites] Br J Cancer. 2000 May;82(9):1585-92 [10789729.001]
  • [Cites] Hum Genet. 1997 Nov;101(1):1-5 [9385359.001]
  • [Cites] Pediatr Blood Cancer. 2008 Jun;50(6):1125-6 [18300307.001]
  • [Cites] Lancet Oncol. 2008 Apr;9(4):319 [18380064.001]
  • [Cites] Int J Cancer. 2008 Mar 15;122(6):1319-23 [18000823.001]
  • [Cites] Trop Med Int Health. 2007 Aug;12(8):936-43 [17697088.001]
  • [Cites] J Natl Cancer Inst. 2007 Jun 20;99(12):962-72 [17565153.001]
  • [Cites] Int J Cancer. 2007 Jan 1;120(1):121-7 [17019706.001]
  • [Cites] Am J Trop Med Hyg. 2006 Aug;75(2):219-25 [16896122.001]
  • [Cites] Nat Genet. 1993 Sep;5(1):56-61 [8220424.001]
  • [Cites] IARC Sci Publ. 1985;(60):177-86 [3905588.001]
  • [Cites] IARC Sci Publ. 1985;(60):155-64 [4065944.001]
  • [Cites] IARC Sci Publ. 1984;(63):665-74 [6536627.001]
  • [Cites] J Clin Immunol. 1985 Mar;5(2):65-77 [3886684.001]
  • [Cites] Int J Cancer. 1980 Feb 15;25(2):197-203 [7390649.001]
  • [Cites] Int J Cancer. 1979 Mar 15;23(3):330-6 [437917.001]
  • [Cites] N Engl J Med. 2006 Jun 8;354(23):2419-30 [16760442.001]
  • [Cites] Int J Cancer. 2006 Feb 15;118(4):985-90 [16106415.001]
  • [Cites] Community Dent Health. 2005 Sep;22(3):146-50 [16161877.001]
  • [Cites] West Afr J Med. 2005 Apr-Jun;24(2):139-42 [16092315.001]
  • [Cites] Early Hum Dev. 2005 Jan;81(1):123-9 [15707724.001]
  • [Cites] Nat Rev Microbiol. 2005 Feb;3(2):182-7 [15685227.001]
  • [Cites] Lancet Oncol. 2004 Dec;5(12):738-46 [15581545.001]
  • [Cites] Br J Surg. 1958 Nov;46(197):218-23 [13628987.001]
  • [Cites] J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):527-33 [12679705.001]
  • [Cites] Hematol Oncol Clin North Am. 2003 Jun;17(3):673-96, v [12852650.001]
  • [Cites] Br J Cancer. 1969 Jun;23(2):235-46 [5788031.001]
  • [Cites] Br Med J. 1971 May 29;2(5760):491-2 [4325452.001]
  • [Cites] Lancet. 1974 Jul 6;2(7871):19-22 [4134408.001]
  • [Cites] Ann Intern Med. 1975 Jul;83(1):31-6 [1147436.001]
  • [Cites] Br J Cancer. 1977 May;35(5):668-73 [861150.001]
  • [Cites] Br J Cancer. 1978 Jan;37(1):109-22 [619954.001]
  • [Cites] Nature. 1978 Aug 24;274(5673):756-61 [210392.001]
  • [Cites] AIDS. 2000 Dec 22;14(18):2929-36 [11153674.001]
  • (PMID = 18767045.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / / Z01 CP010150-08; United States / NCI NIH HHS / CP / N02CP31003; United States / NCI NIH HHS / CP / N02-CP-31003; United States / NCI NIH HHS / CA / N01CO12400; United States / NCI NIH HHS / CO / N01-CO-12400
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS54919; NLM/ PMC2574984
  •  go-up   go-down


10. Hesseling P, McCormick P, Kouya F, Soh F, Katayi T, Noglik G, Kidd M, Kenyu E, Ngam I, Tata G: Burkitt lymphoma: residual abdominal tumor volume after induction therapy correlates with outcome. Pediatr Blood Cancer; 2010 Oct;55(4):761-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Burkitt lymphoma: residual abdominal tumor volume after induction therapy correlates with outcome.
  • Staging investigations in the Malawi 2003 BL protocol included abdominal ultrasonography.
  • This sometimes demonstrated tumor that was not palpable.
  • Patients with no palpable tumor following induction with three courses of cyclophosphamide were considered to be in remission, although residual intraabdominal tumor was documented in some by chance.
  • We repeated ultrasonography on day 29 on 22 new patients with non-palpable abdominal BL following induction.
  • The relapse rate after 1 year correlated with the largest residual tumor volume, and was 17% for tumors 0-35 ml, and 75% for tumors > or = 35 ml in volume.
  • [MeSH-major] Abdominal Neoplasms / drug therapy. Burkitt Lymphoma / drug therapy
  • [MeSH-minor] Adolescent. Child. Child, Preschool. Female. Humans. Male. Neoplasm Recurrence, Local. Prospective Studies

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Wiley-Liss, Inc.
  • (PMID = 20589655.001).
  • [ISSN] 1545-5017
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


11. Memon MA, Mohanty S, Das K, Garg I, D'Cruz AL: Hemihypertrophy, renal dysplasia and benign nephromegaly. Pediatr Nephrol; 2005 Jun;20(6):821-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hemihypertrophy is associated with malignant visceral abdominal neoplasms in childhood.

  • Genetic Alliance. consumer health - Hemihypertrophy.
  • Genetic Alliance. consumer health - Renal dysplasia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pediatr. 1947 Oct;31(4):403-14 [20265776.001]
  • [Cites] Med Pediatr Oncol. 1993;21(3):188-92 [8095320.001]
  • [Cites] Med Pediatr Oncol. 1999 Mar;32(3):196-200 [10064187.001]
  • [Cites] Pediatrics. 1970 Jul;46(1):66-73 [4316375.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1972 Dec;116(4):773-7 [4643273.001]
  • [Cites] J Pediatr. 1962 Dec;61:870-9 [13949299.001]
  • [Cites] Radiology. 1975 Apr;115(1):145-8 [164043.001]
  • (PMID = 15785937.001).
  • [ISSN] 0931-041X
  • [Journal-full-title] Pediatric nephrology (Berlin, Germany)
  • [ISO-abbreviation] Pediatr. Nephrol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


12. Cernea D, Cernea N, Berteanu C: [Intra-abdominal pressure on the functions of abdominal and thoracic organs]. Rev Med Chir Soc Med Nat Iasi; 2006 Oct-Dec;110(4):929-37
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intra-abdominal pressure on the functions of abdominal and thoracic organs].
  • [Transliterated title] Efectele presiunii intra-abdominale asupra funcţiei organelor din abdomen şi torace.
  • A certain pressure exists within closed cavities such as the skull, the abdomen, the thorax, therefore allowing a good supplying to the organs inside.
  • Variations of intraabdominal pressure (IAP) over 10 mmHg will cause an intraabdominal hypertension (IAH) altering both the tissue and cell blood pressure and having an impact on some organs, thus achieving the co-called "abdominal compartment syndrome" (ACS).
  • Intraabdominal pressure increase can lead to some negative effects on both the intra- and extra-abdominal organs such as: cardiovascular, renal, respiratory and digestive systems.
  • ACS is defined as a pathologic status originating from the intraabdominal pressure increase over 20-25 mmHg, values determining a perfusion pressure decrease within the abdominal organs (APP).
  • IAP followed by IAH occurs in ileus, abdominal tumors, intraabdominal hemorrhage and in some morbid conditions: obesity, hepatic cirrhosis with ascites, pregnancy.
  • [MeSH-major] Abdomen / physiopathology. Compartment Syndromes / physiopathology. Hypertension

  • MedlinePlus Health Information. consumer health - High Blood Pressure.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17438903.001).
  • [ISSN] 0048-7848
  • [Journal-full-title] Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i
  • [ISO-abbreviation] Rev Med Chir Soc Med Nat Iasi
  • [Language] rum
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Romania
  • [Number-of-references] 18
  •  go-up   go-down


13. Sall I, El Kaoui H, El Khader A, Bounaim A, Ali AA, Bouchentouf SM, Jiddou CO, Zentar A, Sair K: [An abdominal tumor]. Rev Med Interne; 2010 Feb;31(2):149-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [An abdominal tumor].
  • [Transliterated title] Une masse abdominale.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19286284.001).
  • [ISSN] 1768-3122
  • [Journal-full-title] La Revue de medecine interne
  • [ISO-abbreviation] Rev Med Interne
  • [Language] FRE
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


14. Murtaza B, Ali Khan N, Sharif MA, Malik IB, Mahmood A: Modified midline abdominal wound closure technique in complicated/high risk laparotomies. J Coll Physicians Surg Pak; 2010 Jan;20(1):37-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Modified midline abdominal wound closure technique in complicated/high risk laparotomies.
  • OBJECTIVE: To assess the local wound complications in complicated/ high risk laparotomies in terms of wound dehiscence and incisional hernia formation with a modified technique of midline abdominal wound closure.
  • METHODOLOGY: Cases of complicated/high risk abdominal conditions, which required laparotomy, were included in the study.
  • A modified midline abdominal wound closure technique was used.
  • RESULTS: Out of the 36 patients undergoing this surgical technique, 20 (55.55%) had inflammatory/intra-abdominal sepsis, 8 (22.22%) had trauma, 7 (19.44%) had neoplasia and 1 (2.77%) had vascular aetiology.
  • CONCLUSION: Patients with extensive widespread generalized peritonitis and metastatic abdominal tumours need special attention regarding wound closure.
  • This modified technique of midline abdominal wound closure is associated with low incidence of wound dehiscence and incisional hernia formation.
  • [MeSH-major] Abdomen / surgery. Abdominal Neoplasms / surgery. Digestive System Diseases / surgery. Laparotomy / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Hernia, Abdominal / prevention & control. Humans. Male. Middle Aged. Peritonitis / surgery. Surgical Wound Dehiscence / prevention & control. Suture Techniques. Young Adult

  • MedlinePlus Health Information. consumer health - Digestive Diseases.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20141691.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


15. Vandwalle J, Spie R, Jarry G, Agaesse V, Petit J, Saint F: [Pheochromocytoma and cardiogenic failure: an indication for emergency adrenalectomy]. Prog Urol; 2010 Jul;20(7):498-502
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Phéochromocytome et défaillance cardiaque : une indication exceptionnelle de surrénalectomie en urgence ou semi-urgence.
  • The diagnosis of adrenal pheochromocytoma was done in a second step by the association of adrenal tumour on abdominal CT scan and detection of significantly elevated plasma/urine catecholamine.
  • [MeSH-major] Adrenal Gland Neoplasms / complications. Adrenal Gland Neoplasms / surgery. Adrenalectomy. Emergency Treatment. Heart Failure / etiology. Heart Failure / prevention & control. Pheochromocytoma / complications. Pheochromocytoma / surgery. Shock, Cardiogenic / etiology. Shock, Cardiogenic / prevention & control

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Heart Failure.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010. Published by Elsevier Masson SAS.
  • (PMID = 20656271.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


16. Yamada N, Okuse C, Nomoto M, Orita M, Katakura Y, Ishii T, Shinmyo T, Osada H, Maeda I, Yotsuyanagi H, Suzuki M, Itoh F: Obstructive jaundice caused by secondary pancreatic tumor from malignant solitary fibrous tumor of pleura: a case report. World J Gastroenterol; 2006 Aug 14;12(30):4922-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Obstructive jaundice caused by secondary pancreatic tumor from malignant solitary fibrous tumor of pleura: a case report.
  • A 77-year-old man on systemic chemotherapy against postoperative bilateral multiple lung metastases of malignant solitary fibrous tumor of the pleura suffered from pruritus and jaundice.
  • Abdominal computed tomography showed a tumor with peripheral enhancement in the pancreatic head, accompanied with the dilatation of intra- and extra-hepatic bile ducts.
  • He was diagnosed as having obstructive jaundice caused by a pancreatic head tumor.
  • The pancreatic head tumor was presumably diagnosed as the metastasis of malignant solitary fibrous tumor of the pleura, because the findings on the pancreatic head tumor on abdominal CT were similar to those on the primary lung lesion of malignant solitary fibrous tumor of the pleura.
  • The pancreatic tumor grew rapidly after the implantation of metallic stent in the inferior part of the common bile duct.
  • Autopsy revealed a tumor that spread from the pancreatic head to the hepatic hilum.
  • Immunohistochemically the pancreatic head tumor cells were negative for staining of alpha-smooth muscle actin (alpha-SMA) or CD117, but positive for vimentin, CD34 and CD99.
  • These findings are consistent with those on malignant solitary fibrous tumor of the pleura.
  • We report the first case of obstructive jaundice caused by a secondary pancreatic tumor from malignant solitary fibrous tumor of the pleura.
  • [MeSH-major] Jaundice, Obstructive / etiology. Neoplasms, Fibrous Tissue / pathology. Pancreatic Neoplasms / complications. Pancreatic Neoplasms / secondary. Pleural Neoplasms / pathology
  • [MeSH-minor] Aged. Autopsy. Biomarkers, Tumor / blood. Fatal Outcome. Humans. Male

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathol Int. 2001 Sep;51(9):686-90 [11696171.001]
  • [Cites] Ann Thorac Surg. 2002 Jul;74(1):285-93 [12118790.001]
  • [Cites] Clin Cancer Res. 2002 Oct;8(10):3034-8 [12374669.001]
  • [Cites] Semin Thorac Cardiovasc Surg. 2003 Jul;15(3):305-9 [12973709.001]
  • [Cites] Arch Pathol Lab Med. 2004 May;128(5):538-43 [15086281.001]
  • [Cites] J Clin Oncol. 1999 Jan;17(1):25-30 [10458214.001]
  • [Cites] Clin Radiol. 1982 May 3;33(3):297-9 [7075134.001]
  • [Cites] Ann Intern Med. 1985 Apr;102(4):487-90 [2983594.001]
  • [Cites] Surg Gynecol Obstet. 1989 Apr;168(4):345-7 [2928909.001]
  • [Cites] Am J Surg Pathol. 1989 Aug;13(8):640-58 [2665534.001]
  • [Cites] Cancer. 1981 Jun 1;47(11):2678-89 [7260861.001]
  • (PMID = 16937484.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Other-IDs] NLM/ PMC4087636
  •  go-up   go-down


17. Takano M, Yoshikawa T, Kato M, Aida S, Goto T, Furuya K, Kikuchi Y: Primary clear cell carcinoma of the peritoneum: report of two cases and a review of the literature. Eur J Gynaecol Oncol; 2009;30(5):575-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The most common neoplasms of the peritoneum are malignant mesothelioma and serous papillary adenocarcinoma.
  • Case 1, a 53-year-old woman, presented with upper abdominal and pelvic tumors.
  • Case 2, a 66-year-old woman, presented with massive ascites and abdominal tumor.
  • The ovaries and uterine endometrium of these cases were not affected, and the tumors were diagnosed as Stage IIIc CCC of the peritoneum origin.
  • The cases and a review of the literature suggested that residual tumor volume size determines the survival of these patients, and that the tumors show resistance to conventional platinum-based chemotherapy.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Antineoplastic Combined Chemotherapy Protocols. Peritoneal Neoplasms / pathology

  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Eur J Gynaecol Oncol. 2010;31(1):4. Yoshokawa, T [corrected to Yoshikawa, T]
  • (PMID = 19899421.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 7673326042 / irinotecan; Q20Q21Q62J / Cisplatin; XT3Z54Z28A / Camptothecin
  • [Number-of-references] 15
  •  go-up   go-down


18. Raddaoui E, Ameeri S: Abdominal wall endometriosis: a report of 2 cases with primary diagnosis by fine needle aspiration. Acta Cytol; 2010 Mar-Apr;54(2):214-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Abdominal wall endometriosis: a report of 2 cases with primary diagnosis by fine needle aspiration.
  • BACKGROUND: Abdominal wall endometriosis is usually preceded by obstetric operations and occasionally can be spontaneous.
  • The diagnosis can be suspected clinically when there is systemic endometriosis or cyclic pain; otherwise it is difficult to differentiate it from other abdominal tumors and nonneoplastic conditions.
  • Fine needle aspiration is an extremely valuable and safe tool for preoperative evaluation of abdominal wall endometriosis as the disease usually presents as a cutaneous/subcutaneous mass.
  • CASES: Two cases of abdominal wall endometriosis occurred.
  • CONCLUSION: The cytopathologic diagnosis ofendometriosis is feasible, and we need to include endometriosis in the differential diagnosis of an abdominal wall mass in a females.
  • [MeSH-major] Abdominal Wall / pathology. Endometriosis / diagnosis

  • Genetic Alliance. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20391983.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


19. Kitamura T, Ichikawa T, Aikawa Y, Sano Y, Enomoto N, Araki T: [New diagnostic imaging for navigation surgery]. Nihon Geka Gakkai Zasshi; 2008 Mar;109(2):65-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multidetector-row CT provides thin-slice images through the upper abdomen, multiphase abdominal imaging, and 3D images of high quality including CT angiography and multiplanar reformation.
  • The development of MR units provides diffusion-weighted images for detecting abdominal tumors, and the steady-state coherent echo method can be used for imaging of vessels without using contrast media.
  • The 3D images provided in CT and MR imaging facilitate anatomic understanding of tumors and vessels and are useful for preoperative navigation.

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18409582.001).
  • [ISSN] 0301-4894
  • [Journal-full-title] Nihon Geka Gakkai zasshi
  • [ISO-abbreviation] Nihon Geka Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 11
  •  go-up   go-down


20. Corleto VD, Cotesta D, Petramala L, Panzuto F, Pagnini C, Masoni L, Verrienti A, Delle Fave G, Filetti S, Letizia C: Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease. JOP; 2009;10(5):562-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
  • CONTEXT: Patients with von Hippel-Lindau syndrome, a dominantly inherited familial cancer syndrome, develop a variety of tumors in different organ systems which make the clinical management of these patients complex.
  • Two years later, a pancreaticoduodenectomy was performed to remove a pancreatic mass which turned out to be a pancreatic neuroendocrine tumor.
  • After a long period of relative wellness, 21 years after the surgical resection of her primary pancreatic neuroendocrine tumor, abdominal lymph node metastases of pancreatic neuroendocrine origin occurred.
  • In fact, three abdominal nodules were removed by laparoscopic surgery, and the histological examination showed well-differentiated neuroendocrine tumors with similar immunohistochemical characteristics and Ki67 below 1%.
  • Considering the patient's clinical history, an inherited cause was postulated and multiple endocrine neoplasia type 1 was first investigated, but the result was negative.
  • CONCLUSION: Although no local and/or distant tumor recurrences are usually reported in radically operated on von Hippel-Lindau pancreatic neuroendocrine tumor patients after a median time of five years of follow-up, the present patient had a recurrence after a very long period of time, suggesting that a pancreatic neuroendocrine tumor associated with von Hippel-Lindau syndrome may behave more aggressively than that has previously been described, thus requiring a life-long follow-up.
  • [MeSH-major] Neuroendocrine Tumors / pathology. Neuroendocrine Tumors / surgery. Pancreatic Neoplasms / pathology. Pancreatic Neoplasms / surgery. von Hippel-Lindau Disease / complications
  • [MeSH-minor] Adrenal Gland Neoplasms / pathology. Female. Humans. Lymphatic Metastasis. Middle Aged. Pancreaticoduodenectomy. Pheochromocytoma / pathology. Recurrence. Time Factors

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • MedlinePlus Health Information. consumer health - Von Hippel-Lindau Disease.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19734639.001).
  • [ISSN] 1590-8577
  • [Journal-full-title] JOP : Journal of the pancreas
  • [ISO-abbreviation] JOP
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


21. Banik S, Rangayyan RM, Boag GS: Landmarking of computed tomographic images to assist in segmentation of abdominal tumors caused by neuroblastoma. Conf Proc IEEE Eng Med Biol Soc; 2008;2008:3126-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Landmarking of computed tomographic images to assist in segmentation of abdominal tumors caused by neuroblastoma.
  • Segmentation of the primary tumor mass in neuroblastoma could aid radiologists by facilitating reproducible and objective quantification of the tumor's tissue composition and size.
  • However, due to the heterogeneous nature of the tissue components of the neuroblastic tumor, ranging from low-attenuation necrosis to high-attenuation calcification, some of which possess strong similarities with adjacent nontumoral tissues in computed tomographic (CT) images, segmentation of the tumor is a difficult problem.
  • In this context, landmarking methods are proposed to assist in the segmentation of neuroblastic tumors.
  • The use of the landmarks assisted in limiting the scope of the tumor segmentation process to the abdomen, and resulted in the reduction of the false-positive error rates by 26.9%, on the average, over 10 CT exams, and improved the result of segmentation of neuroblastic tumors.
  • [MeSH-major] Abdominal Neoplasms / pathology. Abdominal Neoplasms / secondary. Brain Neoplasms / pathology. Neuroblastoma / pathology. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Abdomen / pathology. Adolescent. Adult. Child. Child, Preschool. Diagnosis, Computer-Assisted. False Positive Reactions. Humans. Infant. Infant, Newborn. Least-Squares Analysis. Radiographic Image Interpretation, Computer-Assisted. Reproducibility of Results


22. Hunold A, Alzen G, Wudy SA, Bluetters-Sawatzki R, Landmann E, Reiter A, Wagner HJ: Ovarian tumor in a 12-year old female with severe hypothyroidism: A case of Van Wyk and Grumbach syndrome. Pediatr Blood Cancer; 2009 May;52(5):677-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ovarian tumor in a 12-year old female with severe hypothyroidism: A case of Van Wyk and Grumbach syndrome.
  • We report a 12-year-old female presenting with an abdominal tumor.
  • We refrained from ovariectomy, which would be necessary for a malignant tumor, in view of an evident Van Wyk and Grumbach syndrome.
  • [MeSH-major] Hypothyroidism / complications. Hypothyroidism / pathology. Ovarian Cysts / complications. Ovarian Cysts / pathology. Ovarian Neoplasms / complications. Ovarian Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Hypothyroidism.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cysts.
  • Hazardous Substances Data Bank. LEVOTHYROXINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 Wiley-Liss, Inc.
  • (PMID = 19127572.001).
  • [ISSN] 1545-5017
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] Q51BO43MG4 / Thyroxine
  •  go-up   go-down


23. Chang SC, Liao JW: Mesojejunoileac liposarcoma with intrahepatic metastasis in a dog. J Vet Med Sci; 2008 Jun;70(6):637-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The patient was an 8-year-old, male Dachshund, and was referred to our hospital owing to the significant distention of the left abdomen.
  • Neither radiography nor ultrasonography detected the actual association of the tumor with the abdominal viscera before surgery.
  • A large-sized tumor mass that adhered to the mesojejunoileum was explored by laparatomy.

  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18628610.001).
  • [ISSN] 0916-7250
  • [Journal-full-title] The Journal of veterinary medical science
  • [ISO-abbreviation] J. Vet. Med. Sci.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; 80168379AG / Doxorubicin; U3P01618RT / Fluorouracil
  •  go-up   go-down


24. Ramírez-Ortega MA, Villegas-Romero J, Márquez-Díaz A, Gómez-Díaz A: [A cystic mesenteric lymphangioma presented at the colon sigmoid. Case report]. Rev Med Inst Mex Seguro Soc; 2010 Sep-Oct;48(5):557-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Linfangioma quístico de mesenterio en colon sigmoides. Informe de un caso.
  • BACKGROUND: Cystic lymphangioma of the mesentery is an uncommon tumor; its incidence is 1:160,000.
  • CLINICAL CASE: Female 25 years, attending consultation with a clinical picture suggestive of right ovarian cyst and increased abdominal perimeter.
  • On physical examination abdominal painful tumor was identified, with deep palpation and mobilization.
  • Abdominal ultrasound findings suggested giant right ovarian cyst.
  • CONCLUSIONS: Cystic lymphangioma of the mesentery is a benign abdominal tumor, which occurs frequently in children but in adults is rare.
  • [MeSH-major] Lymphangioma, Cystic. Mesentery. Neoplasms, Multiple Primary. Peritoneal Neoplasms. Sigmoid Neoplasms

  • Genetic Alliance. consumer health - Lymphangioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21205508.001).
  • [ISSN] 0443-5117
  • [Journal-full-title] Revista médica del Instituto Mexicano del Seguro Social
  • [ISO-abbreviation] Rev Med Inst Mex Seguro Soc
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Mexico
  •  go-up   go-down


25. Katzenstein HM, Petricca S, Ricketts R, Wasilewski-Masker K, Powell C, Rapkin L, George B, Woods WG, Olson TA: Intracavitary cisplatin therapy for pediatric malignancies. Pediatr Blood Cancer; 2010 Sep;55(3):452-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Local control is essential for the successful treatment of pediatric solid tumors.
  • The aim of the study was to determine the toxicity and efficacy of locally instilled intracavitary cisplatin in patients with recurrent tumors in closed body cavities.
  • PROCEDURE: From 2001 to 2009, 12 patients (1-20 years) with recurrent or unresectable malignant tumors were treated with IC-CDDP.
  • Three patients had abdominal tumors.
  • Three patients are alive and disease-free, 18 months, 4 years, and 6 years from treatment.
  • CONCLUSIONS: IC-CDDP was effective in treating malignant pleural effusions and may be a palliative option for refractory disease.
  • [MeSH-major] Antineoplastic Agents / administration & dosage. Cisplatin / administration & dosage. Peritoneal Neoplasms / drug therapy. Thoracic Neoplasms / drug therapy


26. Jimeno A, Li J, Messersmith WA, Laheru D, Rudek MA, Maniar M, Hidalgo M, Baker SD, Donehower RC: Phase I study of ON 01910.Na, a novel modulator of the Polo-like kinase 1 pathway, in adult patients with solid tumors. J Clin Oncol; 2008 Dec 1;26(34):5504-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase I study of ON 01910.Na, a novel modulator of the Polo-like kinase 1 pathway, in adult patients with solid tumors.
  • PATIENTS AND METHODS: Patients had solid tumors refractory to standard therapy.
  • Toxicities were skeletal, abdominal, and tumor pain; nausea; urge to defecate; and fatigue.
  • [MeSH-minor] Aged. Cell Division. Dose-Response Relationship, Drug. Female. G2 Phase. Humans. Male. Middle Aged. Neoplasms. Time Factors. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. GLYCINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Clin Oncol. 2008 Dec 1;26(34):5497-9 [18955441.001]
  • (PMID = 18955447.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA006973; United States / NCI NIH HHS / CA / P30 CA006973-48
  • [Publication-type] Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Cell Cycle Proteins; 0 / ON 01910; 0 / Proto-Oncogene Proteins; 0 / Sulfones; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.1 / polo-like kinase 1; TE7660XO1C / Glycine
  • [Other-IDs] NLM/ NIHMS443729; NLM/ PMC4824307
  •  go-up   go-down


27. Cay A, Imamoglu M, Cobanoglu U: Eosinophilic pancreatitis mimicking pancreatic neoplasia. Can J Gastroenterol; 2006 May;20(5):361-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Eosinophilic pancreatitis mimicking pancreatic neoplasia.
  • Eosinophilic pancreatitis (EP) is a rare disease.
  • EP usually presents as a pancreatic tumour with abdominal pain and/or obstructive jaundice.
  • The diagnosis is often not made until after pancreatic resection under suspicion of a pancreatic tumour.
  • The case of a 14-year-old boy whose initial presentation was suggestive of a pancreatic tumour is reported.
  • Radiological evaluation revealed a pancreatic mass suggestive of a pancreatic tumour obstructing the duodenum and common bile duct.
  • [MeSH-major] Pancreatic Neoplasms / diagnosis. Pancreatitis / diagnosis

  • Genetic Alliance. consumer health - Pancreatitis.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Diagn Pathol. 2000 Dec;4(6):379-85 [11149970.001]
  • [Cites] Am J Surg Pathol. 2003 Mar;27(3):334-42 [12604889.001]
  • [Cites] Gastrointest Endosc. 2003 Sep;58(3):445-8 [14528227.001]
  • [Cites] Pancreas. 1998 Nov;17(4):419-22 [9821185.001]
  • [Cites] Gastroenterol Clin Biol. 1989 Aug-Sep;13(8-9):731-3 [2806807.001]
  • [Cites] J Med. 1997;28(3-4):265-72 [9355030.001]
  • [Cites] South Med J. 2004 Sep;97(9):905-6 [15455985.001]
  • (PMID = 16691304.001).
  • [ISSN] 0835-7900
  • [Journal-full-title] Canadian journal of gastroenterology = Journal canadien de gastroenterologie
  • [ISO-abbreviation] Can. J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Glucocorticoids
  • [Other-IDs] NLM/ PMC2659896
  •  go-up   go-down


28. Moore MO, Richardson ML, Rubin BP, Baird GS: Abdominal cavity myolipoma presenting as an enlarging incisional hernia. Radiol Case Rep; 2006;1(1):7-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Abdominal cavity myolipoma presenting as an enlarging incisional hernia.
  • We present a case of an abdominal cavity myolipoma which herniated through a low transverse abdominal (Pfannenstiel) incision, and presented as an enlarging abdominal wall mass.
  • Magnetic resonance imaging (MRI) prior to surgery demonstrated an encapsulated solid tumor mass demonstrating fat signal and and increased T2-weighted signal.
  • Recognition of the intra- and extraperitoneal location of this abdominal tumor was essential for accurate surgical planning.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27298672.001).
  • [ISSN] 1930-0433
  • [Journal-full-title] Radiology case reports
  • [ISO-abbreviation] Radiol Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Other-IDs] NLM/ PMC4891403
  • [Keywords] NOTNLM ; 3D, three dimensional / CT, computed tomography / MB, megabyte / MRI, magnetic resonance imaging / STIR, short tau inversion recovery
  •  go-up   go-down


29. Salles VJ, Coaglio RC, Lima AR, Destro C, Salgado FC, Brito HP, Segundo WG: [Postoperative abdominal tumor: a diagnostic dilemma]. Acta Gastroenterol Latinoam; 2006 Dec;36(4):168, 230
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Postoperative abdominal tumor: a diagnostic dilemma].
  • [Transliterated title] Tumor abdominal pós-operatório: um dilema diagnóstico.
  • [MeSH-major] Foreign Bodies / diagnosis. Gastrointestinal Stromal Tumors / diagnosis

  • MedlinePlus Health Information. consumer health - Foreign Bodies.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17225441.001).
  • [ISSN] 0300-9033
  • [Journal-full-title] Acta gastroenterologica Latinoamericana
  • [ISO-abbreviation] Acta Gastroenterol. Latinoam.
  • [Language] spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Argentina
  •  go-up   go-down


30. Asito AS, Piriou E, Odada PS, Fiore N, Middeldorp JM, Long C, Dutta S, Lanar DE, Jura WG, Ouma C, Otieno JA, Moormann AM, Rochford R: Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study. Infect Agent Cancer; 2010;5:13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study.
  • BACKGROUND: Endemic Burkitt's lymphoma (BL) is an extranodal tumor appearing predominantly in the jaw in younger children while abdominal tumors predominate with increasing age.
  • However, these studies have neither determined if there were any differences based on the site of clinical presentation of the tumor nor examined a broader panel of EBV and P. falciparum antigens.
  • Interestingly, when we grouped BL patients into those presenting with abdominal tumors or with jaw tumors, we observed significantly higher levels of anti-Zta IgG levels (p < 0.0065) and plasma EBV viral loads (p < 0.033) in patients with abdominal tumors compared to patients with jaw tumors.
  • CONCLUSION: Elevated antibodies to Zta and elevated plasma EBV viral load could be relevant biomarkers for BL and could also be used to confirm BL presenting in the abdominal region.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Semin Cancer Biol. 2009 Dec;19(6):377-88 [19619657.001]
  • [Cites] J Gen Virol. 1995 Jun;76 ( Pt 6):1393-400 [7540196.001]
  • [Cites] J Infect Dis. 1994 Jul;170(1):13-9 [8014488.001]
  • [Cites] Cancer. 1980 Mar 15;45(6):1507-15 [6244085.001]
  • [Cites] Nature. 1978 Aug 24;274(5673):756-61 [210392.001]
  • [Cites] Lancet. 1977 Feb 12;1(8007):335-8 [64861.001]
  • [Cites] Nat Rev Cancer. 2004 Oct;4(10):757-68 [15510157.001]
  • [Cites] Arch Pathol Lab Med. 2004 May;128(5):549-52 [15086279.001]
  • [Cites] Cytometry. 2002 Oct 15;50(5):239-42 [12360572.001]
  • [Cites] Int J Cancer. 2002 Jun 10;99(5):635-43 [12115495.001]
  • [Cites] Int J Cancer. 2009 Apr 1;124(7):1721-6 [19089927.001]
  • [Cites] Nat Rev Microbiol. 2008 Dec;6(12):913-24 [19008891.001]
  • [Cites] Clin Vaccine Immunol. 2008 Nov;15(11):1684-8 [18768669.001]
  • [Cites] Int J Cancer. 2008 Dec 1;123(11):2658-63 [18767045.001]
  • [Cites] PLoS One. 2008;3(6):e2505 [18560562.001]
  • [Cites] Int J Cancer. 2008 Mar 15;122(6):1319-23 [18000823.001]
  • [Cites] J Clin Virol. 2008 Feb;41(2):96-103 [18024156.001]
  • [Cites] AIDS. 2007 Oct 18;21(16):2141-9 [18090040.001]
  • [Cites] Trop Med Int Health. 2007 Aug;12(8):936-43 [17697088.001]
  • [Cites] Int J Cancer. 2007 Jan 1;120(1):121-7 [17019706.001]
  • [Cites] Singapore Med J. 2006 Sep;47(9):803-7 [16924363.001]
  • [Cites] J Infect Dis. 2005 Apr 15;191(8):1233-8 [15776368.001]
  • [Cites] Anticancer Res. 2004 Nov-Dec;24(6):4059-66 [15736452.001]
  • [Cites] Nat Rev Microbiol. 2005 Feb;3(2):182-7 [15685227.001]
  • [Cites] East Afr Med J. 2004 Aug;(8 Suppl):S111-6 [15622609.001]
  • [Cites] Int J Cancer. 1999 Mar 31;81(1):6-11 [10077144.001]
  • [Cites] J Med Virol. 1999 Apr;57(4):383-9 [10089051.001]
  • [Cites] J Infect Dis. 1999 May;179(5):1108-15 [10191211.001]
  • [Cites] Ann Med. 1998 Jun;30(3):249-59 [9677010.001]
  • [Cites] Pediatr Pathol Lab Med. 1997 May-Jun;17(3):391-400 [9185219.001]
  • [Cites] Blood. 1996 Jun 15;87(12):5279-86 [8652843.001]
  • [Cites] Blood. 1995 Jul 15;86(2):659-65 [7605996.001]
  • [Cites] J Med Virol. 2009 Jun;81(6):1088-93 [19382256.001]
  • (PMID = 20667138.001).
  • [ISSN] 1750-9378
  • [Journal-full-title] Infectious agents and cancer
  • [ISO-abbreviation] Infect. Agents Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA102667
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2923120
  •  go-up   go-down


31. Hammerstingl RM, Vogl TJ: Abdominal MDCT: protocols and contrast considerations. Eur Radiol; 2005 Dec;15 Suppl 5:E78-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Abdominal MDCT: protocols and contrast considerations.
  • This results in improved lesion detection of benign as well as malignant abdominal tumours.
  • The ability to scan through the entire abdomen in seconds allows multiphasic acquisitions.
  • Hypervascularized solid abdominal tumours are best depicted within the time generally regarded as the arterial dominant phase in MDCT, conversely hypovascular lesions are best depicted during venous phase imaging.
  • The acquisition of an early arterial phase provides precise documentation of the arterial vascular system and should be obtained in preoperative abdominal imaging.
  • Three clear separate circulatory phases enable best results in the pretherapeutic work-up of abdominal patients.
  • Regarding follow-up oncologic work-up in colorectal metastatic disease a venous dominant phase might be the optimal protocol.
  • Especially for hypervascular tumours, e.g.
  • The overall improvement in precise timing and better visibility enable a comprehensive approach to abdominal imaging in MDCT.
  • [MeSH-major] Radiography, Abdominal / methods. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18637234.001).
  • [ISSN] 0938-7994
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 27
  •  go-up   go-down


32. Gore RM, Newmark GM, Thakrar KH, Mehta UK, Berlin JW: Pathways of abdominal tumour spread: the role of the subperitoneal space. Cancer Imaging; 2009;9:112-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pathways of abdominal tumour spread: the role of the subperitoneal space.
  • This space is formed by the subserosal areolar tissue that lines the inner surfaces of the peritoneum and the musculature of the abdomen and pelvis.
  • The subperitoneal space extends into the peritoneal cavity and is invested between the layers of the mesenteries and ligaments that support and interconnect the abdominal and pelvic organs.
  • As such, it provides one large continuous space in which infectious, neoplastic, inflammatory, and hemorrhagic disease may spread in many directions.
  • [MeSH-major] Abdominal Cavity / pathology. Abdominal Neoplasms / pathology. Neoplasm Metastasis / pathology
  • [MeSH-minor] Carcinoma / pathology. Digestive System Neoplasms / pathology. Humans. Ligaments / anatomy & histology. Ligaments / pathology. Lymphatic Metastasis. Magnetic Resonance Imaging. Mesentery / anatomy & histology. Mesentery / pathology. Omentum / anatomy & histology. Omentum / pathology. Peritoneal Neoplasms / secondary. Retroperitoneal Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiographics. 2005 Jul-Aug;25(4):983-95 [16009819.001]
  • [Cites] J Comput Assist Tomogr. 1982 Dec;6(6):1127-37 [7174930.001]
  • [Cites] Radiology. 1984 Feb;150(2):485-90 [6691106.001]
  • [Cites] AJR Am J Roentgenol. 1985 Jun;144(6):1223-7 [3890486.001]
  • [Cites] Gastrointest Radiol. 1986;11(2):142-4 [3514354.001]
  • [Cites] J Comput Assist Tomogr. 1987 Mar-Apr;11(2):258-63 [3819124.001]
  • [Cites] Radiology. 1987 Jun;163(3):593-604 [3575702.001]
  • [Cites] Radiology. 1987 Jun;163(3):637-9 [3575707.001]
  • [Cites] Gastrointest Radiol. 1988 Oct;13(4):285-98 [3049207.001]
  • [Cites] Radiology. 1989 Jul;172(1):35-40 [2544924.001]
  • [Cites] Radiographics. 2001 Nov-Dec;21(6):1475-90 [11706218.001]
  • [Cites] Radiographics. 2003 Mar-Apr;23(2):457-73; quiz 535-6 [12640160.001]
  • [Cites] Radiographics. 2003 May-Jun;23(3):687-701 [12740470.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1973 Feb;117(2):263-74 [4685855.001]
  • [Cites] Radiology. 1973 Sep;108(3):497-504 [4723648.001]
  • [Cites] Radiology. 1973 Sep;108(3):505-12 [4723649.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1973 Sep;119(1):151-65 [4744721.001]
  • [Cites] Radiology. 1989 Jul;172(1):41-6 [2662255.001]
  • [Cites] AJR Am J Roentgenol. 1997 Mar;168(3):683-7 [9057515.001]
  • (PMID = 20080454.001).
  • [ISSN] 1470-7330
  • [Journal-full-title] Cancer imaging : the official publication of the International Cancer Imaging Society
  • [ISO-abbreviation] Cancer Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2821589
  •  go-up   go-down


33. Shoja MM, Tubbs RS, Loukas M, Shokouhi G, Ghabili K, Agutter PS: The sub-peritoneal arterial plexus of Sir William Turner. Ann Anat; 2010 Aug 20;192(4):194-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • His classic paper of 1863 on the anastomoses between the parietal and visceral branches of the abdominal aorta, later known as the sub-peritoneal arterial plexus of Turner, has mostly been forgotten.
  • In the current paper, we discuss the sub-peritoneal arterial plexus as described by Turner in 1863 and review the literature concerning its potential clinical significance in the kidney, emphasizing its probable role in the metastatic spread of various tumors of abdominal organs and in the continuing viability of the kidney after renal artery occlusion.
  • [MeSH-minor] Anatomy / history. Aorta, Abdominal / anatomy & histology. Connective Tissue / blood supply. England. History, 19th Century. History, 20th Century. Humans. Intra-Abdominal Fat / blood supply. Neoplasm Metastasis. Peritoneum

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010. Published by Elsevier GmbH.
  • (PMID = 20634049.001).
  • [ISSN] 1618-0402
  • [Journal-full-title] Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft
  • [ISO-abbreviation] Ann. Anat.
  • [Language] eng
  • [Publication-type] Biography; Historical Article; Journal Article; Portraits; Review
  • [Publication-country] Germany
  • [Personal-name-as-subject] Turner W
  •  go-up   go-down


34. Glasgow CG, Steagall WK, Taveira-Dasilva A, Pacheco-Rodriguez G, Cai X, El-Chemaly S, Moses M, Darling T, Moss J: Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies. Respir Med; 2010 Jul;104 Suppl 1:S45-58
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • LAM is a rare lung disease, found primarily in women of childbearing age, characterized by cystic lung destruction and abdominal tumors (e.g., renal angiomyolipoma, lymphangioleiomyoma).
  • The disease results from proliferation of a neoplastic cell, termed the LAM cell, which has mutations in either of the tuberous sclerosis complex (TSC) 1 or TSC2 genes.
  • Occurrence of LAM essentially entirely in women is consistent with the hypothesis that anti-estrogen agents might prevent disease progression (e.g., gonadotropin-releasing hormone analogues).
  • [MeSH-major] Cyclin-Dependent Kinase Inhibitor p21 / therapeutic use. Lung Neoplasms. Lymphangioleiomyomatosis. Rare Diseases
  • [MeSH-minor] Disease Progression. Female. Gene Expression Regulation, Neoplastic / genetics. Humans. Phenotype. Prognosis. TOR Serine-Threonine Kinases / antagonists & inhibitors. TOR Serine-Threonine Kinases / metabolism. Tumor Suppressor Proteins / genetics

  • Genetic Alliance. consumer health - Lymphangioleiomyomatosis.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Rare Diseases.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010. Published by Elsevier Ltd.
  • [Cites] Cancer Res. 1998 Aug 15;58(16):3719-26 [9721884.001]
  • [Cites] Am J Respir Crit Care Med. 2006 Jan 1;173(1):105-11 [16210669.001]
  • [Cites] Mol Cell. 2006 Apr 21;22(2):159-68 [16603397.001]
  • [Cites] Clin Chest Med. 2006 Jun;27(2):355-68 [16716823.001]
  • [Cites] Tumori. 2006 Mar-Apr;92(2):149-54 [16724695.001]
  • [Cites] N Engl J Med. 2006 Jun 15;354(24):2621-2 [16775248.001]
  • [Cites] Lymphat Res Biol. 2006;4(2):83-100 [16808670.001]
  • [Cites] Genes Dev. 2006 Jul 1;20(13):1715-20 [16818603.001]
  • [Cites] J Biol Chem. 1999 Dec 10;274(50):35647-52 [10585443.001]
  • [Cites] Arch Pathol Lab Med. 2000 Feb;124(2):267-75 [10656737.001]
  • [Cites] Radiology. 2000 Feb;214(2):441-6 [10671592.001]
  • [Cites] Eur J Biochem. 2000 May;267(9):2505-15 [10785369.001]
  • [Cites] Nat Cell Biol. 2000 May;2(5):281-7 [10806479.001]
  • [Cites] Nat Cell Biol. 2000 May;2(5):E76-8 [10806489.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 May 23;97(11):6085-90 [10823953.001]
  • [Cites] Mayo Clin Proc. 2000 Jun;75(6):591-4 [10852420.001]
  • [Cites] Science. 2001 Nov 30;294(5548):1942-5 [11729323.001]
  • [Cites] J Hum Genet. 2002;47(1):20-8 [11829138.001]
  • [Cites] Radiology. 2002 Apr;223(1):189-97 [11930066.001]
  • [Cites] Genes Dev. 2002 Jun 15;16(12):1472-87 [12080086.001]
  • [Cites] Physiol Rev. 2002 Jul;82(3):673-700 [12087132.001]
  • [Cites] Cell. 2002 Jul 26;110(2):177-89 [12150926.001]
  • [Cites] Mol Cell. 2002 Jul;10(1):151-62 [12150915.001]
  • [Cites] J Biol Chem. 2002 Aug 23;277(34):30958-67 [12045200.001]
  • [Cites] Nat Cell Biol. 2002 Sep;4(9):648-57 [12172553.001]
  • [Cites] Nat Cell Biol. 2002 Sep;4(9):699-704 [12172555.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13571-6 [12271141.001]
  • [Cites] Mol Cell. 2002 Sep;10(3):457-68 [12408816.001]
  • [Cites] Thorax. 2002 Dec;57(12):1085-6 [12454306.001]
  • [Cites] Nature. 2002 Dec 12;420(6916):691-5 [12478298.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Jan;4(1):33-45 [12511867.001]
  • [Cites] Expert Opin Ther Targets. 2003 Feb;7(1):35-48 [12556201.001]
  • [Cites] Hum Pathol. 2003 Jan;34(1):95-8 [12605373.001]
  • [Cites] J Womens Health (Larchmt). 2003 Jan-Feb;12(1):81-5 [12639372.001]
  • [Cites] Am J Respir Crit Care Med. 2003 Apr 1;167(7):976-82 [12411287.001]
  • [Cites] Nat Cell Biol. 2003 Jun;5(6):578-81 [12771962.001]
  • [Cites] Curr Biol. 2003 Aug 5;13(15):1259-68 [12906785.001]
  • [Cites] J Biol Chem. 2003 Aug 29;278(35):32493-6 [12842888.001]
  • [Cites] Int J Cancer. 2003 Nov 20;107(4):541-50 [14520690.001]
  • [Cites] Genes Chromosomes Cancer. 2003 Dec;38(4):376-81 [14566858.001]
  • [Cites] Cell. 2003 Nov 26;115(5):577-90 [14651849.001]
  • [Cites] Carcinogenesis. 2003 Dec;24(12):1871-8 [12949055.001]
  • [Cites] Am J Respir Crit Care Med. 2003 Dec 15;168(12):1427-31 [12958050.001]
  • [Cites] Chest. 2004 Jan;125(1):135-42 [14718432.001]
  • [Cites] Genes Chromosomes Cancer. 2005 Mar;42(3):213-27 [15578690.001]
  • [Cites] AJR Am J Roentgenol. 2005 Feb;184(2):459-64 [15671364.001]
  • [Cites] Science. 2005 Feb 18;307(5712):1098-101 [15718470.001]
  • [Cites] J Appl Physiol (1985). 2005 May;98(5):1892-9 [15829722.001]
  • [Cites] Am J Respir Crit Care Med. 2005 May 15;171(10):1150-7 [15640367.001]
  • [Cites] J Exp Med. 2005 Sep 5;202(5):617-24 [16129702.001]
  • [Cites] Am J Surg Pathol. 2005 Oct;29(10):1356-66 [16160479.001]
  • [Cites] Mol Cell Biol. 2006 Jan;26(1):362-70 [16354706.001]
  • [Cites] Endocrinology. 1997 Oct;138(10):4308-15 [9322944.001]
  • [Cites] Cancer Res. 1998 Apr 1;58(7):1395-9 [9537238.001]
  • [Cites] Am J Hum Genet. 1998 Apr;62(4):810-5 [9529362.001]
  • [Cites] Hum Mol Genet. 1998 Jun;7(6):1053-7 [9580671.001]
  • [Cites] Curr Pharm Des. 2009;15(7):742-57 [19275640.001]
  • [Cites] AJR Am J Roentgenol. 2009 Apr;192(4):1037-44 [19304711.001]
  • [Cites] Curr Opin Cell Biol. 2009 Apr;21(2):230-6 [19237273.001]
  • [Cites] Curr Opin Cell Biol. 2009 Apr;21(2):209-18 [19261457.001]
  • [Cites] Chest. 2009 May;135(5):1293-300 [19420197.001]
  • [Cites] J Invest Dermatol. 2009 Jun;129(6):1471-82 [18971959.001]
  • [Cites] Biochim Biophys Acta. 2009 Sep;1791(9):949-55 [19264150.001]
  • [Cites] Radiology. 2000 Jul;216(1):147-53 [10887241.001]
  • [Cites] J Nippon Med Sch. 2000 Oct;67(5):311-29 [11031360.001]
  • [Cites] Hum Pathol. 2000 Oct;31(10):1242-8 [11070117.001]
  • [Cites] Arch Pathol Lab Med. 2000 Nov;124(11):1642-8 [11079017.001]
  • [Cites] Thorax. 2000 Dec;55(12):1052-7 [11083892.001]
  • [Cites] Cancer Lett. 2000 Dec 20;161(2):207-14 [11090971.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Nov 11;278(1):140-3 [11185526.001]
  • [Cites] Int J Cancer. 2001 Jan 1;91(1):67-75 [11149422.001]
  • [Cites] Am J Med Sci. 2001 Jan;321(1):17-25 [11202475.001]
  • [Cites] Oncogene. 2000 Dec 14;19(54):6306-16 [11175345.001]
  • [Cites] Nat Med. 2001 Feb;7(2):186-91 [11175849.001]
  • [Cites] Nature. 2001 Mar 1;410(6824):50-6 [11242036.001]
  • [Cites] Am J Surg Pathol. 2001 Apr;25(4):479-84 [11257622.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):813-20 [11448356.001]
  • [Cites] J Cardiovasc Pharmacol. 2001 Sep;38(3):395-405 [11486244.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Aug 15;164(4):661-8 [11520734.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Aug 15;164(4):669-71 [11520735.001]
  • [Cites] Nat Med. 2006 Oct;12(10):1167-74 [16998484.001]
  • [Cites] Lymphat Res Biol. 2006;4(3):143-52 [17034294.001]
  • [Cites] Cancer Control. 2006 Oct;13(4):276-85 [17075565.001]
  • [Cites] Histopathology. 2007 Feb;50(3):338-47 [17257129.001]
  • [Cites] Blood. 2007 Apr 15;109(8):3509-12 [17179228.001]
  • [Cites] Endocr Rev. 2007 May;28(3):297-321 [17409287.001]
  • [Cites] Respirology. 2007 Jul;12(4):523-30 [17587419.001]
  • [Cites] Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4617-22 [17671152.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L800-8 [17616646.001]
  • [Cites] Cancer Res. 2007 Nov 1;67(21):10573-81 [17975002.001]
  • [Cites] Science. 2007 Nov 9;318(5852):977-80 [17991864.001]
  • [Cites] Chest. 2007 Nov;132(5):1573-8 [17890459.001]
  • [Cites] N Engl J Med. 2008 Jan 10;358(2):140-51 [18184959.001]
  • [Cites] N Engl J Med. 2008 Jan 10;358(2):199-200 [18184970.001]
  • [Cites] Genes Dev. 2008 Jan 15;22(2):239-51 [18198340.001]
  • [Cites] Chest. 2008 Feb;133(2):448-54 [18071009.001]
  • [Cites] J Clin Endocrinol Metab. 2008 May;93(5):1625-33 [18285421.001]
  • [Cites] Mol Cell Biol. 2008 Jun;28(12):4104-15 [18411301.001]
  • [Cites] Science. 2008 Jun 13;320(5882):1496-501 [18497260.001]
  • [Cites] Mol Cell. 2008 Jun 20;30(6):701-11 [18570873.001]
  • [Cites] Cancer Res. 2008 Aug 15;68(16):6496-506 [18701472.001]
  • [Cites] Lymphat Res Biol. 2008;6(3-4):165-72 [19093789.001]
  • [Cites] J Immunol. 2009 Feb 1;182(3):1270-7 [19155472.001]
  • [Cites] Amino Acids. 2009 Feb;36(2):297-302 [18386114.001]
  • [Cites] Nat Rev Cancer. 2009 Mar;9(3):153-66 [19238148.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2635-40 [19202070.001]
  • [Cites] Mol Cell Biol. 2009 Mar;29(6):1411-20 [19114562.001]
  • [Cites] Endocr Relat Cancer. 2009 Mar;16(1):59-72 [18988705.001]
  • [Cites] Br J Cancer. 2004 Apr 5;90(7):1414-21 [15054465.001]
  • [Cites] Cancer Immunol Immunother. 2004 Jul;53(7):567-79 [14762695.001]
  • [Cites] Respir Med. 2004 Jun;98(6):536-41 [15191039.001]
  • [Cites] Am J Surg Pathol. 2004 Aug;28(8):1007-16 [15252306.001]
  • [Cites] Curr Biol. 2004 Jul 27;14(14):1296-302 [15268862.001]
  • [Cites] Thorax. 2004 Sep;59(9):800-3 [15333859.001]
  • [Cites] Ann Surg Oncol. 2004 Oct;11(10):928-33 [15383417.001]
  • [Cites] Amino Acids. 2004 Oct;27(2):119-28 [15351877.001]
  • [Cites] Kans Med. 1986 Oct;87(10):277-8, 293 [3807098.001]
  • [Cites] Chest. 1987 May;91(5):782-5 [3032524.001]
  • [Cites] J Biol Chem. 1988 Sep 25;263(27):13916-21 [3166460.001]
  • [Cites] Am J Surg Pathol. 1989 Sep;13(9):803-7 [2764227.001]
  • [Cites] Am J Clin Pathol. 1990 May;93(5):609-14 [2183584.001]
  • [Cites] N Engl J Med. 1990 Nov 1;323(18):1254-60 [2215609.001]
  • [Cites] Hum Pathol. 1990 Dec;21(12):1252-61 [2249838.001]
  • [Cites] Cancer Res. 1998 Nov 1;58(21):4766-70 [9809973.001]
  • [Cites] Cancer Res. 1999 Jan 1;59(1):219-26 [9892210.001]
  • [Cites] Chest. 1999 Apr;115(4):1041-52 [10208206.001]
  • [Cites] Anticancer Res. 1999 Jan-Feb;19(1B):671-5 [10216475.001]
  • [Cites] Cancer Chemother Pharmacol. 1999;43 Suppl:S42-51 [10357558.001]
  • [Cites] Am J Respir Crit Care Med. 1999 Aug;160(2):628-33 [10430739.001]
  • [Cites] Am J Respir Cell Mol Biol. 1999 Sep;21(3):327-36 [10460750.001]
  • [Cites] Medicine (Baltimore). 1999 Sep;78(5):321-37 [10499073.001]
  • [Cites] J Biol Chem. 2004 Nov 19;279(47):48707-15 [15355997.001]
  • [Cites] Cancer Sci. 2004 Dec;95(12):930-5 [15596040.001]
  • [Cites] Chest. 2004 Dec;126(6):1867-74 [15596686.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17462-7 [15583138.001]
  • [Cites] Pediatr Res. 2005 Jan;57(1):67-75 [15557109.001]
  • [Cites] Oncogene. 2001 Aug 9;20(35):4904-9 [11521203.001]
  • [Cites] J Biol Chem. 2001 Oct 5;276(40):37258-65 [11486009.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Sep 15;164(6):1072-6 [11587999.001]
  • [Cites] Radiology. 2001 Nov;221(2):415-21 [11687685.001]
  • [Cites] Am Rev Respir Dis. 1991 Jan;143(1):174-6 [1824744.001]
  • [Cites] Cell. 1991 Apr 5;65(1):13-24 [1707342.001]
  • [Cites] Ann N Y Acad Sci. 1991;615:125-7 [2039137.001]
  • [Cites] Am J Clin Pathol. 1991 Oct;96(4):529-35 [1716416.001]
  • [Cites] Eur J Med. 1993 Jun-Jul;2(6):377-8 [8252188.001]
  • [Cites] Cell. 1993 Dec 31;75(7):1305-15 [8269512.001]
  • [Cites] Thorax. 1994 Sep;49(9):910-4 [7940433.001]
  • [Cites] Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):527-33 [7842216.001]
  • [Cites] Hum Mol Genet. 1994;3 Spec No:1477-80 [7849741.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3566-70 [7724599.001]
  • [Cites] Cancer Chemother Pharmacol. 1995;36(5):418-24 [7543375.001]
  • [Cites] Nature. 1995 Oct 5;377(6548):441-6 [7566123.001]
  • [Cites] Chest. 1996 Jan;109(1):131-7 [8549175.001]
  • [Cites] Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1368-76 [8616568.001]
  • [Cites] Eur Respir J. 1996 Mar;9(3):402-5 [8729995.001]
  • [Cites] Rev Mal Respir. 1996 Jul;13(3):300-4 [8765924.001]
  • [Cites] Int J Gynaecol Obstet. 1996 Mar;52(3):289-90 [8775689.001]
  • [Cites] Development. 1996 Dec;122(12):3829-37 [9012504.001]
  • [Cites] Arch Biochem Biophys. 1997 Jul 15;343(2):157-63 [9224725.001]
  • [Cites] Science. 1997 Aug 8;277(5327):805-8 [9242607.001]
  • [Cites] Hum Pathol. 1997 Sep;28(9):1071-8 [9308732.001]
  • (PMID = 20630348.001).
  • [ISSN] 1532-3064
  • [Journal-full-title] Respiratory medicine
  • [ISO-abbreviation] Respir Med
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 HL002541-12; United States / Intramural NIH HHS / / Z01 HL002541-13; United States / Intramural NIH HHS / / ZIA HL002541-14
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Tumor Suppressor Proteins; 0 / tuberous sclerosis complex 1 protein; 4JG2LF96VF / tuberous sclerosis complex 2 protein; EC 2.7.1.1 / TOR Serine-Threonine Kinases
  • [Other-IDs] NLM/ NIHMS206406; NLM/ PMC3030250
  •  go-up   go-down


35. Pereira Arias JG, Ullate Jaime V, Gutiérrez Díez JM, Ateca Díaz-Obregón R, Ramírez Rodríguez MM, Pereda Martínez E, Berreteaga Gallastegui JR: [Concurrent tumors in a patient with giant hydronephrosis]. Arch Esp Urol; 2006 Jan-Feb;59(1):84-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Concurrent tumors in a patient with giant hydronephrosis].
  • METHODS/RESULTS: We report the case of a 66-year-old male under study for a suspicious digestive tumor due to a long lasting clinical picture with severe cachexia, asthenia, anemia, constipation, and abdominal mass.
  • It may present as an asymptomatic process, with clinical features of abdominal organs compression (bowel or urinary obstruction) or simulate abdominal tumors, massive ascites, or cystic retroperitoneal lesions.
  • Nevertheless, in some cases, in compromised patients, percutaneous drainage may be necessary as previous or definitive treatment to avoid changes in the hemodynamic balance secondary to the sudden abdominal decompression.
  • [MeSH-major] Carcinoma, Renal Cell / complications. Carcinoma, Transitional Cell / complications. Hydronephrosis / etiology. Kidney Neoplasms / complications. Neoplasms, Multiple Primary / complications

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16568700.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


36. Orosz Z, Balázs D, Sápi Z, Tiszlavicz L, Tornóczky T: [Reclassification of gastrointestinal mesenchymal tumors]. Magy Onkol; 2006;50(4):287-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Reclassification of gastrointestinal mesenchymal tumors].
  • A retrospective (1985-2005) multicentric evaluation of the pathological diagnoses of GIST (gastrointestinal stromal tumor) in Hungary was performed.
  • A large cohort of 463 patients with abdominal mesenchymal tumors was reevaluated with the help of immunohistochemistry for CD117, CD34, desmin and S100.
  • Beside GIST, 81 leiomyogenic and 25 neurogenic tumors were the primary pathological diagnosis and in 74/255 cases the primary diagnosis was a benign tumor.
  • Based on our experience, in case of abdominal tumors of uncertain localization, immunohistochemical markers of CD117, CD34, S100 and desmin provide a proper tool for precise identification of the tumor entity including GIST.
  • [MeSH-major] Biomarkers, Tumor / analysis. Gastrointestinal Stromal Tumors / classification. Gastrointestinal Stromal Tumors / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17216001.001).
  • [ISSN] 0025-0244
  • [Journal-full-title] Magyar onkologia
  • [ISO-abbreviation] Magy Onkol
  • [Language] hun
  • [Publication-type] English Abstract; Journal Article; Multicenter Study
  • [Publication-country] Hungary
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


37. Grabellus F, Dereskewitz C, Schmitz KJ, Kaiser GM, Kühl H, Kersting C, Frilling A, Metz KA, Baba HA: [Two cystic retroperitoneal lesions mimicking adrenal cysts]. Pathologe; 2005 May;26(3):226-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adrenal cysts are uncommon lesions and most of them are found incidentally during abdominal imaging.
  • We report on two benign extraadrenal lesions mimicking adrenal tumors in abdominal imaging.

  • MedlinePlus Health Information. consumer health - Adrenal Gland Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1996 Nov;201(2):541-8 [8888255.001]
  • [Cites] Ann Surg. 1988 Aug;208(2):184-9 [3401062.001]
  • [Cites] Mod Pathol. 2002 May;15(5):492-501 [12011254.001]
  • [Cites] Eur J Radiol. 2002 Feb;41(2):95-112 [11809539.001]
  • [Cites] Thorax. 1994 Mar;49(3):287-8 [8202890.001]
  • [Cites] J Urol. 1959 Jun;81(6):711-9 [13655392.001]
  • [Cites] Am J Surg Pathol. 1988 Apr;12(4):275-81 [3354753.001]
  • [Cites] Int J Urol. 2001 Sep;8(9):500-3 [11683971.001]
  • [Cites] Abdom Imaging. 2002 Sep-Oct;27(5):557-9 [12172997.001]
  • [Cites] Curr Opin Oncol. 2003 Jan;15(1):84-90 [12490767.001]
  • [Cites] Eur J Surg. 1994 Jun-Jul;160(6-7):389-91 [7948360.001]
  • [Cites] Arch Pathol Lab Med. 2001 Jul;125(7):944-7 [11419983.001]
  • (PMID = 15322819.001).
  • [ISSN] 0172-8113
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


38. Wyler S, Huang DJ, Singer G, Schötzau A, Holzgreve W, Güth U: Metastatic involvement of the urinary tract in patients with advanced ovarian carcinoma: lessons from the autopsy for an interdisciplinary treatment approach. Eur J Gynaecol Oncol; 2009;30(2):174-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The distribution of abdominal metastatic sites with particular attention to the involvement of the urologic organs, and hydronephrosis was analyzed.
  • CONCLUSION: Hydronephrosis in late stages of ovarian carcinoma, usually attributed to extrinsic compression of the ureter by an abdominal tumor, may also be explained by ureteral metastases.
  • [MeSH-major] Carcinoma / secondary. Ovarian Neoplasms / pathology. Urologic Neoplasms / secondary
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Kidney Neoplasms / secondary. Middle Aged. Ureteral Neoplasms / secondary. Urinary Bladder Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19480248.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


39. Yamanaka H, Mizushima T, Mikata S, Ito T, Nonaka K, Ide H, Michiura T, Kainuma S, Iwase K: [Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)]. Gan To Kagaku Ryoho; 2005 Dec;32(13):2125-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
  • The prognosis of metastatic or recurrent GISTs is poor, because these tumors resist chemotherapy and radiotherapy.
  • A 64-year-old man presented with large intra-abdominal mass.
  • The abdominal mass was phi3 x 3.5 cm in size with ascites at Douglas, as determined by computed tomography, and was diagnosed as a peritoneal relapse of GIST.
  • After 1 month of treatment with imatinib, reduction of the abdominal tumor began to be recognized on palpation.
  • Computed tomographic scanning at 11 months revealed that the tumor had completely disappeared.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Gastrointestinal Stromal Tumors / drug therapy. Jejunal Neoplasms / drug therapy. Peritoneal Neoplasms / drug therapy. Piperazines / therapeutic use. Pyrimidines / therapeutic use

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • Hazardous Substances Data Bank. IMATINIB MESYLATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16352942.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate
  •  go-up   go-down


40. Vuković M, Krivokuća D, Moljević N: Malignant peritoneal mesothelioma: a case report. Acta Chir Belg; 2009 May-Jun;109(3):408-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this paper we report a case of malignant peritoneal mesothelioma, a rare abdominal tumour.
  • A 72-year-old male with a medical history of heart disease presented to our Clinic because of pain in the right half of the abdomen.
  • Diagnostic procedures, including clinical and laboratory examination, X-ray, ultrasonography and computed tomography, revealed a tumour in the right lower quadrant of the abdomen.
  • The approximate size of the tumour size at initial detection was 7 cm.
  • During the pre-operative procedure an evident growth of the tumour was noticed, indicating exploratory laparotomy.
  • Intra-operative findings revealed a large tumour of the anterolateral abdominal wall, involving the greater omentum.
  • Tumour resection was performed, as well as resection of the portion of the anterolateral abdominal wall and omentectomy.
  • [MeSH-major] Laparotomy / methods. Mesothelioma / diagnosis. Peritoneal Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Mesothelioma, malignant.
  • MedlinePlus Health Information. consumer health - Mesothelioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19943603.001).
  • [ISSN] 0001-5458
  • [Journal-full-title] Acta chirurgica Belgica
  • [ISO-abbreviation] Acta Chir. Belg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


41. Rudloff U, Bhanot U, Gerald W, Klimstra DS, Jarnagin WR, Brennan MF, Allen PJ: Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality. Ann Surg Oncol; 2010 Aug;17(8):2229-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A prospective institutional review board-approved protocol for the banking of abdominal neoplasms was initiated at Memorial Sloan-Kettering Cancer Center in 2001.
  • [MeSH-major] Pancreatic Neoplasms. RNA, Neoplasm / analysis. Specimen Handling / methods. Tissue Banks

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • Biospecimen Research Database. Biospecimen Research Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Pathol. 2002 Apr;160(4):1239-49 [11943709.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3344-50 [19064549.001]
  • [Cites] Am J Clin Pathol. 2002 Nov;118(5):733-41 [12428794.001]
  • [Cites] Am J Pathol. 2004 Mar;164(3):903-14 [14982844.001]
  • [Cites] Biotechniques. 2004 Jun;36(6):1030-7 [15211754.001]
  • [Cites] Exp Mol Pathol. 2004 Oct;77(2):98-103 [15351232.001]
  • [Cites] Am J Clin Pathol. 1999 Mar;111(3):304-7 [10078104.001]
  • [Cites] Cancer Res. 2005 Mar 1;65(5):1619-26 [15753353.001]
  • [Cites] Nucleic Acids Res. 2005;33(6):e56 [15800207.001]
  • [Cites] FASEB J. 2005 Aug;19(10):1356-8 [15955843.001]
  • [Cites] J Clin Oncol. 2005 Oct 10;23(29):7350-60 [16145060.001]
  • [Cites] Oncogene. 2005 Oct 6;24(44):6626-36 [16103885.001]
  • [Cites] Nature. 2006 Jan 19;439(7074):353-7 [16273092.001]
  • [Cites] Lab Invest. 2006 Feb;86(2):202-11 [16402036.001]
  • [Cites] Mol Aspects Med. 2006 Apr-Jun;27(2-3):126-39 [16469371.001]
  • [Cites] BMC Mol Biol. 2006;7:3 [16448564.001]
  • [Cites] J Clin Oncol. 2006 Aug 10;24(23):3763-70 [16822846.001]
  • [Cites] N Engl J Med. 2006 Aug 10;355(6):570-80 [16899777.001]
  • [Cites] J Biotechnol. 2007 Jan 20;127(4):549-59 [16945445.001]
  • [Cites] BMC Mol Biol. 2007;8:38 [17519006.001]
  • [Cites] J Neurosci Methods. 2007 Sep 30;165(2):198-209 [17628689.001]
  • [Cites] Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R226-32 [17911165.001]
  • [Cites] Cancer. 2007 Oct 15;110(8):1641-3 [17763370.001]
  • [Cites] Eur Urol. 2008 Feb;53(2):333-44 [17448597.001]
  • [Cites] Clin Cancer Res. 2008 Jan 1;14(1):270-80 [18172279.001]
  • [Cites] Ann Surg Oncol. 2008 May;15(5):1356-66 [18256882.001]
  • [Cites] JAMA. 2008 Apr 2;299(13):1574-87 [18387932.001]
  • [Cites] Clin Cancer Res. 2008 Sep 15;14(18):5672-7 [18794074.001]
  • [Cites] Am J Pathol. 2002 Nov;161(5):1743-8 [12414521.001]
  • (PMID = 20162455.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA008748
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Neoplasm
  • [Other-IDs] NLM/ NIHMS479692; NLM/ PMC3877690
  •  go-up   go-down


42. Xanthoulis A, Mirelis C, Markakidis S, Bougioukas I, Bekiaridou K, Tsalkidou E, Zafeiropoulos G, Tentes AA: Complete cytoreduction combined with early postoperative intraperitoneal chemotherapy for ovarian carcinosarcoma. Report of two cases. Gynecol Obstet Invest; 2006;62(2):100-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Two middle-aged women with palpable abdominal tumors underwent complete cytoreductive surgery and no macroscopic tumor was left behind.
  • RESULTS: The patients are disease-free 2 and 3 years, respectively after the initial therapy.
  • [MeSH-major] Antibiotics, Antineoplastic / therapeutic use. Carcinosarcoma / surgery. Doxorubicin / therapeutic use. Ovarian Neoplasms / surgery

  • Genetic Alliance. consumer health - Ovarian carcinosarcoma.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16645301.001).
  • [ISSN] 0378-7346
  • [Journal-full-title] Gynecologic and obstetric investigation
  • [ISO-abbreviation] Gynecol. Obstet. Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 80168379AG / Doxorubicin
  •  go-up   go-down


43. Juárez Azpilcueta A, Buitrón García R, Peláez González H, Bravo Gutiérrez R, Rivas López R: [Fetal ovarian cyst. A report of a case]. Ginecol Obstet Mex; 2005 Apr;73(4):212-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Quiste de ovario fetal. Presentación de un caso.
  • Fetal ovarian cyst is uncommon; it represents the second place of fetal abdominal tumors, after urinary tract tumors.
  • [MeSH-major] Cystadenoma, Serous / embryology. Ovarian Neoplasms / embryology. Ultrasonography, Prenatal

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21966758.001).
  • [ISSN] 0300-9041
  • [Journal-full-title] Ginecología y obstetricia de México
  • [ISO-abbreviation] Ginecol Obstet Mex
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


44. Semczuk A, Skorupski P, Olcha P, Skomra D, Rechberger T, Gogacz M: Giant uterine leiomyomas causing bilateral hydronephrosis coexisting with endometrial cancer in polyp: a case study. Eur J Gynaecol Oncol; 2009;30(3):344-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 50-year-old woman was admitted due to bilateral hydronephrosis caused by monstrous abdominal tumor to the IInd Department of Gynecology, Lublin Medical University, Lublin, Poland.
  • Pelvic examination revealed a huge, rough tumor, originating from the uterus.
  • Total abdominal hysterectomy with bilateral salpingo-oophorectomy was performed, and a giant uterus weighing 15.2 kg and measuring 35 x 29 x 18 cm was removed.
  • [MeSH-major] Endometrial Neoplasms / pathology. Hydronephrosis / etiology. Leiomyoma / pathology. Neoplasms, Multiple Primary / pathology. Polyps / pathology. Uterine Neoplasms / pathology

  • Genetic Alliance. consumer health - Endometrial cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19697639.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


45. Mazonakis M, Zacharopoulou F, Kachris S, Varveris C, Damilakis J, Gourtsoyiannis N: Scattered dose to gonads and associated risks from radiotherapy for common pediatric malignancies : a phantom study. Strahlenther Onkol; 2007 Jun;183(6):332-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIAL AND METHODS: Radiotherapy for central nervous system tumors, acute leukemia, neuroblastoma, Hodgkin's disease, Wilms' tumor, and sarcoma was simulated on three humanoid phantoms representing patients of 5, 10, and 15 years of age.
  • Gonadal dose from radiotherapy for abdominal tumors was measured using an 18-MV photon beam.
  • RESULTS: For a tumor dose range of 12-55 Gy, the scattered dose to ovaries was 0.5-62.4 cGy depending upon the patient's age (corresponding phantom) and treatment site.
  • Abdominal irradiation with 18-MV instead of 6-MV X-rays reduced the gonadal dose by more than 1.3 times.
  • [MeSH-major] Neoplasms / radiotherapy. Ovary / radiation effects. Radiation Injuries / etiology. Scattering, Radiation. Testis / radiation effects. Thermoluminescent Dosimetry

  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17520188.001).
  • [ISSN] 0179-7158
  • [Journal-full-title] Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
  • [ISO-abbreviation] Strahlenther Onkol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


46. Shin IS, Maeng JS, Jang BS, You E, Cheng K, Li KC, Wood B, Carrasquillo JA, Danthi SN, Paik CH: Tc-labeling of Peptidomimetic Antagonist to Selectively Target alpha(v)beta(3) Receptor-Positive Tumor: Comparison of PDA and EDDA as co-Ligands. Curr Radiopharm; 2010 Jan 01;3(1):1-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tc-labeling of Peptidomimetic Antagonist to Selectively Target alpha(v)beta(3) Receptor-Positive Tumor: Comparison of PDA and EDDA as co-Ligands.
  • OBJECTIVES: The aim of this research was to synthesize radiolabeled peptidomimetic integrin alpha(v)beta(3) antagonist with (99m)Tc for rapid targeting of integrin alpha(v)beta(3) receptors in tumor to produce a high tumor to background ratio.
  • Their differences shown in serum stability and the receptor-binding appeared to be related to their biological behaviors in tumor uptake and retention; the 1 h tumor uptakes of P1 and P2 were 3.17+/-0.52 and 2.13+/-0.17 % ID/g, respectively.
  • P1 was retained in the tumor longer than P2.
  • These findings were supported by imaging studies showing higher tumor-to-abdominal contrast for P1 than for P2 at 3 h postinjection.
  • CONCLUSIONS: P1 showed good tumor targeting properties with a rapid tumor uptake, prolonged tumor retention and fast whole-body clearance kinetics.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nucl Med Biol. 2003 Aug;30(6):605-15 [12900286.001]
  • [Cites] Nucl Med Biol. 2003 Feb;30(2):141-9 [12623113.001]
  • [Cites] Int J Cancer. 2000 Aug 20;90(4):186-98 [10993959.001]
  • [Cites] Nucl Med Biol. 2006 Nov;33(8):945-52 [17127166.001]
  • [Cites] J Nucl Med. 1999 Jun;40(6):1061-71 [10452325.001]
  • [Cites] Cancer Biother Radiopharm. 2003 Aug;18(4):627-41 [14503959.001]
  • [Cites] Nat Biotechnol. 1997 Jun;15(6):542-6 [9181576.001]
  • [Cites] Bioconjug Chem. 2007 Mar-Apr;18(2):438-46 [17341108.001]
  • [Cites] Mol Imaging Biol. 2004 Sep-Oct;6(5):350-9 [15380745.001]
  • [Cites] Bioorg Med Chem. 2005 Jun 1;13(11):3763-71 [15863003.001]
  • [Cites] Bioconjug Chem. 2007 May-Jun;18(3):821-8 [17375899.001]
  • [Cites] Bioconjug Chem. 2004 Jul-Aug;15(4):864-71 [15264875.001]
  • [Cites] Bioconjug Chem. 2004 Mar-Apr;15(2):235-41 [15025518.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1081-9 [15118844.001]
  • [Cites] Bioconjug Chem. 2005 Nov-Dec;16(6):1580-8 [16287258.001]
  • [Cites] J Nucl Med. 2004 Oct;45(10 ):1776-83 [15471848.001]
  • [Cites] J Nucl Med. 2005 Oct;46(10 ):1707-18 [16204722.001]
  • [Cites] Nuklearmedizin. 2004 Feb;43(1):26-32 [14978538.001]
  • [Cites] J Nucl Med. 2001 Feb;42(2):326-36 [11216533.001]
  • [Cites] J Nucl Med. 2000 Jun;41(6):1114-9 [10855644.001]
  • [Cites] Cell. 1986 Feb 28;44(4):517-8 [2418980.001]
  • [Cites] Nucl Med Biol. 2007 May;34(4):363-70 [17499725.001]
  • [Cites] Nucl Med Biol. 2004 Jan;31(1):11-9 [14741566.001]
  • [Cites] Bioconjug Chem. 2008 Mar;19(3):634-42 [18281926.001]
  • [Cites] Neoplasia. 2005 Mar;7(3):271-9 [15799827.001]
  • [Cites] Q J Nucl Med Mol Imaging. 2007 Mar;51(1):33-41 [17372571.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1215-27 [15001266.001]
  • (PMID = 20556233.001).
  • [ISSN] 1874-4729
  • [Journal-full-title] Current radiopharmaceuticals
  • [ISO-abbreviation] Curr Radiopharm
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 CL025001-06; United States / Intramural NIH HHS / / Z01 CL025001-07; United States / Intramural NIH HHS / / Z99 CL999999; United States / Intramural NIH HHS / / ZIA CL025001-08
  • [Publication-type] Journal Article
  • [Publication-country] United Arab Emirates
  •  go-up   go-down


47. Drăghici I, Drăghici L, Popescu M, Liţescu M: Exploratory laparoscopy--diagnosis method in pediatric surgery pathology. J Med Life; 2009 Jul-Sep;2(3):288-95
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The motivations for exploratory laparoscopic procedures are multiple and arise from many causes, from right lower quadrant pain syndrome and abdominal tumors to congenital malformations and non-palpable testis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20112473.001).
  • [ISSN] 1844-122X
  • [Journal-full-title] Journal of medicine and life
  • [ISO-abbreviation] J Med Life
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


48. Monill J, Pernas J, Montserrat E, Pérez C, Clavero J, Martinez-Noguera A, Guerrero R, Torrubia S: CT features of abdominal plasma cell neoplasms. Eur Radiol; 2005 Aug;15(8):1705-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CT features of abdominal plasma cell neoplasms.
  • The aim of this study was to describe the CT features of abdominal plasma cell neoplasms.
  • We reviewed CT imaging findings in 11 patients (seven men, four women; mean age 62 years) with plasma cell neoplasms and abdominal involvement.
  • Helical CT of the entire abdomen and pelvis was performed following intravenous administration of contrast material.
  • All patients with multiple myeloma had multifocal disease with involvement of perirenal space (4/7), retroperitoneal and pelvic lymph nodes (3/7), peritoneum (3/7), liver (2/7), subcutaneous tissues (2/7) and kidney (1/7).
  • In the fourth patient, a double site of abdominal involvement was observed with rectal and jejunal masses.
  • Plasma cell neoplasm should be considered in the differential diagnosis of single or multiple enhancing masses in the abdomen or pelvis.
  • Abdominal plasma cell neoplasms were most frequently seen as well-defined enhancing masses (10/11).
  • [MeSH-major] Abdominal Neoplasms / diagnostic imaging. Multiple Myeloma / diagnostic imaging. Pelvic Neoplasms / diagnostic imaging. Plasmacytoma / diagnostic imaging. Tomography, Spiral Computed

  • MedlinePlus Health Information. consumer health - Multiple Myeloma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Imaging. 2000 Nov-Dec;24(6):365-7 [11368939.001]
  • [Cites] Medicine (Baltimore). 1980 Sep;59(5):380-92 [7432154.001]
  • [Cites] Cancer. 1990 Jun 15;65(12):2784-6 [2111206.001]
  • [Cites] J R Soc Med. 1987 Mar;80(3):182-4 [3572948.001]
  • [Cites] Abdom Imaging. 1999 Sep-Oct;24(5):508-10 [10475938.001]
  • [Cites] Cancer. 1969 Jan;23(1):167-74 [5763250.001]
  • [Cites] AJR Am J Roentgenol. 2002 Jan;178(1):245-7 [11756137.001]
  • [Cites] Am J Hematol. 2001 May;67(1):1-5 [11279649.001]
  • [Cites] Australas Radiol. 1999 Feb;43(1):98-101 [10901880.001]
  • [Cites] AJR Am J Roentgenol. 1999 Nov;173(5):1266-8 [10541102.001]
  • [Cites] J Comput Assist Tomogr. 1985 Nov-Dec;9(6):1118-9 [3902920.001]
  • [Cites] Int J Hematol. 1993 Dec;59(1):59-65 [8161736.001]
  • [Cites] Hum Pathol. 1994 Mar;25(3):308-18 [8150462.001]
  • [Cites] AJR Am J Roentgenol. 1993 Nov;161(5):1083-7 [8273615.001]
  • [Cites] Eur Radiol. 2003 May;13(5):1154-64 [12695840.001]
  • [Cites] Cancer. 1982 Jul 1;50(1):146-9 [7083118.001]
  • [Cites] Hinyokika Kiyo. 2001 Sep;47(9):629-31 [11692599.001]
  • [Cites] Eur Radiol. 2003 Jun;13(6):1224-34 [12764636.001]
  • [Cites] Dis Colon Rectum. 1981 Nov-Dec;24(8):633-5 [7318632.001]
  • [Cites] Cancer. 1999 Jun 1;85(11):2305-14 [10357398.001]
  • [Cites] Ann Oncol. 1992 Jan;3(1):51-7 [1606070.001]
  • [Cites] Abdom Imaging. 1993 Fall;18(4):323-4 [8220028.001]
  • [Cites] AJR Am J Roentgenol. 2003 Sep;181(3):888 [12933502.001]
  • [Cites] J Comput Assist Tomogr. 1986 Jan-Feb;10 (1):144-5 [3511106.001]
  • [Cites] AMA Arch Pathol. 1952 Mar;53(3):262-72 [14902231.001]
  • [Cites] J Clin Pathol. 1994 Mar;47(3):269-71 [8163701.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2002;9(1):111-5 [12021905.001]
  • [Cites] Cancer. 1992 Mar 15;69(6):1513-7 [1540888.001]
  • [Cites] Cancer. 1980 Oct 15;46(8):1893-5 [7427893.001]
  • [Cites] Am J Surg Pathol. 1995 Oct;19(10):1197-202 [7573678.001]
  • [Cites] Cancer. 1979 Mar;43(3):1007-13 [106950.001]
  • [Cites] Eur Radiol. 2003 Apr;13(4):771-9 [12664116.001]
  • [Cites] Acta Clin Belg. 1983;38(6):384-7 [6673438.001]
  • [Cites] Radiol Med. 1987 Jun;73(6):584-6 [3602487.001]
  • [Cites] Leuk Lymphoma. 1999 Apr;33(3-4):389-92 [10221521.001]
  • [Cites] J Clin Oncol. 1983 Apr;1(4):255-62 [6668499.001]
  • (PMID = 16034641.001).
  • [ISSN] 0938-7994
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


49. Ueda S, Yamada Y, Tsuji Y, Kawaguchi R, Haruta S, Shigetomi H, Kanayama S, Yoshida S, Sakata M, Sado T, Kitanaka K, Kobayashi H: Giant abdominal tumor of the ovary. J Obstet Gynaecol Res; 2008 Feb;34(1):108-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant abdominal tumor of the ovary.
  • A giant abdominal tumor can exert a mass effect on surrounding structures.
  • We report here a 34-year-old single female who presented with an increased abdominal girth and was subsequently found to have a giant abdominal mass.
  • [MeSH-major] Cystadenoma, Serous / diagnosis. Hypotension / prevention & control. Ovarian Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Low Blood Pressure.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18226141.001).
  • [ISSN] 1341-8076
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 12
  •  go-up   go-down


50. Baskar AA, Ignacimuthu S, Paulraj GM, Al Numair KS: Chemopreventive potential of beta-Sitosterol in experimental colon cancer model--an in vitro and In vivo study. BMC Complement Altern Med; 2010;10:24
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Asclepias curassavica Linn. is a traditional medicinal plant used by tribal people in the western ghats, India, to treat piles, gonorrhoea, roundworm infestation and abdominal tumours.
  • [MeSH-major] Adenocarcinoma / prevention & control. Antineoplastic Agents, Phytogenic / pharmacology. Antioxidants / therapeutic use. Colonic Neoplasms / prevention & control. Plant Extracts / therapeutic use. Sitosterols / therapeutic use
  • [MeSH-minor] Animals. Apoptosis / drug effects. Asclepias / chemistry. Cell Line. Cell Line, Tumor. Colon / drug effects. Colon / metabolism. Colon / pathology. Disease Models, Animal. Dose-Response Relationship, Drug. Haplorhini. Humans. Kidney / drug effects. Male. Phytotherapy. Proliferating Cell Nuclear Antigen / metabolism. Rats. Rats, Wistar. beta Catenin / metabolism

  • MedlinePlus Health Information. consumer health - Antioxidants.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biochem Soc Trans. 2005 Aug;33(Pt 4):672-5 [16042571.001]
  • [Cites] Phytochemistry. 2005 May;66(10):1186-91 [15924924.001]
  • [Cites] Nitric Oxide. 2006 Feb;14(1):72-88 [16288976.001]
  • [Cites] Nat Cell Biol. 2006 May;8(5):501-8 [16604061.001]
  • [Cites] Biochim Biophys Acta. 2006 Aug;1760(8):1175-83 [16733082.001]
  • [Cites] Bioorg Med Chem. 2007 Jul 15;15(14):4923-32 [17512744.001]
  • [Cites] Int Immunopharmacol. 2007 Aug;7(8):1044-53 [17570321.001]
  • [Cites] Phytomedicine. 2007 Nov;14(11):747-54 [17350814.001]
  • [Cites] Hum Exp Toxicol. 2008 Jun;27(6):505-11 [18784204.001]
  • [Cites] Clin Neurol Neurosurg. 2009 May;111(4):345-51 [19117666.001]
  • [Cites] Int J Mol Med. 2000 May;5(5):541-5 [10762659.001]
  • [Cites] J Nutr. 2000 Sep;130(9):2127-30 [10958802.001]
  • [Cites] Nature. 2000 Nov 9;408(6809):239-47 [11089981.001]
  • [Cites] Free Radic Biol Med. 2003 Nov 1;35(9):1073-81 [14572610.001]
  • [Cites] Nat Rev Cancer. 2004 Mar;4(3):206-15 [14993902.001]
  • [Cites] J Natl Cancer Inst. 2004 May 5;96(9):662-72 [15126603.001]
  • [Cites] J Immunol Methods. 1983 Dec 16;65(1-2):55-63 [6606682.001]
  • [Cites] Nature. 1987 Apr 2-8;326(6112):515-7 [2882423.001]
  • [Cites] Cancer Lett. 1987 Oct 30;37(2):147-51 [3677050.001]
  • [Cites] Cancer Res. 1988 Nov 1;48(21):6187-92 [3167865.001]
  • [Cites] FEBS Lett. 1995 Jan 16;358(1):1-3 [7821417.001]
  • [Cites] J Immunol Methods. 1995 Jul 17;184(1):39-51 [7622868.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Jan 13;230(2):254-7 [9016760.001]
  • [Cites] Cancer Res. 1998 Jan 1;58(1):42-6 [9426055.001]
  • [Cites] J Cell Biochem Suppl. 1997;27:35-41 [9591191.001]
  • [Cites] Oncogene. 1998 Sep 17;17(11 Reviews):1343-52 [9779982.001]
  • [Cites] EMBO J. 1999 Jun 1;18(11):3054-63 [10357817.001]
  • [Cites] Cancer. 1999 Aug 15;86(4):672-83 [10440696.001]
  • [Cites] Science. 1964 Dec 25;146(3652):1685-6 [14224519.001]
  • [Cites] Prostaglandins Leukot Essent Fatty Acids. 2005 Mar;72(3):219-26 [15664307.001]
  • [Cites] Oncol Rep. 2005 Aug;14(2):345-51 [16012713.001]
  • [Cites] Free Radic Biol Med. 2005 Jul 1;39(1):91-7 [15925281.001]
  • [Cites] Cancer Sci. 2005 Dec;96(12):876-81 [16367907.001]
  • (PMID = 20525330.001).
  • [ISSN] 1472-6882
  • [Journal-full-title] BMC complementary and alternative medicine
  • [ISO-abbreviation] BMC Complement Altern Med
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Antioxidants; 0 / Plant Extracts; 0 / Proliferating Cell Nuclear Antigen; 0 / Sitosterols; 0 / beta Catenin; 5LI01C78DD / gamma-sitosterol
  • [Other-IDs] NLM/ PMC2887773
  •  go-up   go-down


51. Groen SP: [Diagnostic image (338). An old woman with an abdominal swelling]. Ned Tijdschr Geneeskd; 2007 Aug 25;151(34):1878
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnostic image (338). An old woman with an abdominal swelling].
  • [Transliterated title] Diagnose in beeld (338). een bejaarde vrouw met een zwelling van de buik.
  • A 90-year-old woman who injected insulin in the abdominal wall and used a platelet inhibitor, had a massive abdominal tumour which turned out to be a rectus sheath haematoma.

  • MedlinePlus Health Information. consumer health - Blood Thinners.
  • MedlinePlus Health Information. consumer health - Muscle Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Ned Tijdschr Geneeskd. 2007 Nov 3;151(44):2480 [18064870.001]
  • (PMID = 17902561.001).
  • [ISSN] 0028-2162
  • [Journal-full-title] Nederlands tijdschrift voor geneeskunde
  • [ISO-abbreviation] Ned Tijdschr Geneeskd
  • [Language] dut
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Insulin; 0 / Platelet Aggregation Inhibitors
  •  go-up   go-down


52. Johnson PT, Fishman EK: IV contrast selection for MDCT: current thoughts and practice. AJR Am J Roentgenol; 2006 Feb;186(2):406-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The purpose of this article is to review studies evaluating how contrast concentration affects MDCT of the body and to report IV contrast infusion protocols from MDCT angiography and MDCT of abdominal tumors.
  • CONCLUSION: Higher concentrations (350 mg I/mL or greater) may improve visualization of small abdominal arteries.
  • However, preliminary data comparing 300 mg I/mL to higher concentrations for MDCT of hypervascular hepatocellular carcinoma and pancreatic cancer have shown that higher concentrations may not increase tumor conspicuity.
  • [MeSH-major] Angiography. Carcinoma, Hepatocellular / radiography. Contrast Media / administration & dosage. Liver Neoplasms / radiography. Pancreatic Neoplasms / radiography. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16423946.001).
  • [ISSN] 0361-803X
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 78
  •  go-up   go-down


53. Louzi A, Rifki SE, Benamar Y, Attari M, Kafih M, Zerouali NO: [Colonic actinomycosis: report of a case and review of the literature]. Ann Chir; 2005 Feb;130(2):101-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Actinomycose colique: à propos d'un cas et revue de la littérature.
  • Abdominal localizations are rare and simulated a malignant process.
  • We report a colonic actinomycosis case of a 62-year-old woman with a abdominal tumor and diagnosed after surgical resection.
  • [MeSH-minor] Colonic Neoplasms / diagnosis. Diagnosis, Differential. Diagnostic Errors. Female. Humans. Middle Aged

  • Genetic Alliance. consumer health - Anaerobic Actinomyces Infection.
  • MedlinePlus Health Information. consumer health - Colonic Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15737322.001).
  • [ISSN] 0003-3944
  • [Journal-full-title] Annales de chirurgie
  • [ISO-abbreviation] Ann Chir
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 17
  •  go-up   go-down


54. Kobayashi M, Okamoto K, Nakatani H, Okabayashi T, Namikawa T, Ichikawa K, Kitagawa H, Araki K: Complete remission of recurrent gastrointestinal stromal tumors after treatment with imatinib: report of a case. Surg Today; 2006;36(8):727-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complete remission of recurrent gastrointestinal stromal tumors after treatment with imatinib: report of a case.
  • A 49-year-old man underwent partial resection of the jejunum for an abdominal tumor, which was histologically confirmed to be a gastrointestinal stromal tumor (GIST).
  • Immunohistochemistry revealed that the tumor cells were positive for c-kit, p52, and MIB-1.
  • He underwent resection of a total of 83 recurrent tumors over the next 36 months.
  • A computed tomography (CT) scan done a few months later showed multiple tumor recurrences.
  • The patient was started on imatinib mesylate 400 mg/day, and 3 months later, a CT image showed an increase in tumor size but a decrease in tumor density.
  • Subsequent CT scans showed a marked decrease in tumor size 3 months later and no evidence of tumor recurrence 9 and 12 months after the commencement of imatinib treatment.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Gastrointestinal Stromal Tumors / drug therapy. Piperazines / therapeutic use. Protein Kinase Inhibitors / therapeutic use. Protein-Tyrosine Kinases / antagonists & inhibitors. Pyrimidines / therapeutic use

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • Hazardous Substances Data Bank. IMATINIB MESYLATE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 2001 Jun;32(6):578-82 [11431711.001]
  • [Cites] Oncogene. 2001 Aug 16;20(36):5054-8 [11526490.001]
  • [Cites] Ann Surg. 2000 Jan;231(1):51-8 [10636102.001]
  • [Cites] J Natl Cancer Inst. 1991 Jul 3;83(13):926-32 [2067035.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 2;92 (3):205-16 [10655437.001]
  • [Cites] Blood. 2000 Aug 1;96(3):925-32 [10910906.001]
  • [Cites] N Engl J Med. 2001 Apr 5;344(14):1052-6 [11287975.001]
  • [Cites] J Gastroenterol. 2003;38(7):690-4 [12898363.001]
  • [Cites] J Clin Oncol. 2004 Sep 15;22(18):3813-25 [15365079.001]
  • [Cites] N Engl J Med. 2002 Aug 15;347(7):472-80 [12181401.001]
  • [Cites] Histol Histopathol. 2000 Oct;15(4):1293-301 [11005253.001]
  • [Cites] Cancer Sci. 2003 Apr;94(4):315-20 [12824897.001]
  • [Cites] Am J Pathol. 1998 May;152(5):1259-69 [9588894.001]
  • [Cites] Science. 1998 Jan 23;279(5350):577-80 [9438854.001]
  • [Cites] Cell. 1990 Oct 5;63(1):213-24 [1698556.001]
  • [Cites] Int J Clin Oncol. 2003 Jun;8(3):180-3 [12851843.001]
  • [Cites] Gan To Kagaku Ryoho. 2002 Nov;29(12):2329-32 [12484066.001]
  • [Cites] J Pathol. 2001 Apr;193(4):505-10 [11276010.001]
  • [Cites] Lancet. 2001 Oct 27;358(9291):1421-3 [11705489.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2003 Mar;15(3):323-7 [12610329.001]
  • [Cites] J Pharmacol Exp Ther. 2000 Oct;295(1):139-45 [10991971.001]
  • [Cites] Hum Pathol. 1999 Oct;30(10):1213-20 [10534170.001]
  • [Cites] Nat Med. 1996 May;2(5):561-6 [8616716.001]
  • [Cites] Gan To Kagaku Ryoho. 2002 Apr;29(4):607-10 [11977548.001]
  • (PMID = 16865518.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Protein Kinase Inhibitors; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate; EC 2.7.10.1 / Protein-Tyrosine Kinases
  • [Number-of-references] 29
  •  go-up   go-down


55. Meisetschläger G, Poethko T, Stahl A, Wolf I, Scheidhauer K, Schottelius M, Herz M, Wester HJ, Schwaiger M: Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide. J Nucl Med; 2006 Apr;47(4):566-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide.
  • A recently developed (18)F-labeled PET tracer for somatostatin receptor (sstr) imaging, N(alpha)-(1-deoxy-D-fructosyl)-N(epsilon)-(2-[(18)F]fluoropropionyl)-Lys(0)-Tyr(3)-octreotate (Gluc-Lys([(18)F]FP)-TOCA), was evaluated in patients with sstr-positive tumors by assessing the pharmacokinetics, biodistribution, and diagnostic performance in comparison with [(111)In]DTPA-octreotide.
  • METHODS: Twenty-five patients with different sstr-positive tumors were included in the study and were injected with 105 +/- 50 MBq Gluc-Lys([(18)F]FP)-TOCA.
  • Tracer kinetics in tumors and nontumor tissues and tumor-to-background ratios were described by region-of-interest analysis and standardized uptake values (SUVs).
  • RESULTS: Gluc-Lys([(18)F]FP)-TOCA showed a fast and intense tumor accumulation as well as a rapid clearance from blood serum (biexponential elimination, with the half-lives of the initial and the terminal elimination phase calculated as t(1/2)(1) = 2.3 +/- 1.3 min and t(1/2)(2) = 26.4 +/- 14.6 min, respectively).
  • Tumor-to-background ratios at 16 +/- 9 min and 34 +/- 12 min were as high as 80% and 90% (% of maximum ratios), respectively.
  • Tumors showed high SUVs ranging from 13.7 +/- 2.3 (tumors in lung) up to 26.9 +/- 15.4 (abdominal tumors).
  • Tracer distribution within tumor and nontumor tissues was stable up to 120 min (except spleen).
  • Comparison of 29 tumors located in the liver showed a mean tumor-to-background ratio of 5.3 +/- 2.6 for Gluc-Lys([(18)F]FP)-TOCA vs. 4.6 +/- 3.3 for [(111)In]DTPA-octreotide (P = 0.24).
  • CONCLUSION: Gluc-Lys([(18)F]FP)-TOCA PET allows a fast, high- contrast imaging of sstr-positive tumors.
  • [MeSH-major] Fructose / analogs & derivatives. Neoplasms / metabolism. Octreotide / analogs & derivatives. Pentetic Acid / analogs & derivatives. Peptides, Cyclic. Radiopharmaceuticals. Receptors, Somatostatin / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16595488.001).
  • [ISSN] 0161-5505
  • [Journal-full-title] Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • [ISO-abbreviation] J. Nucl. Med.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 111In-octreotide, DTPA(0)-; 0 / Fluorine Radioisotopes; 0 / Indium Radioisotopes; 0 / N(alpha)-(1-deoxy- D-fructosyl)- N(epsilon)-(2-fluoropropionyl)-Lys(0)-Tyr(3)-octreotate; 0 / Peptides, Cyclic; 0 / Radiopharmaceuticals; 0 / Receptors, Somatostatin; 30237-26-4 / Fructose; 7A314HQM0I / Pentetic Acid; RWM8CCW8GP / Octreotide
  •  go-up   go-down


56. de León DC, Pérez-Montiel D, Bandera A, Villegas C, Gonzalez-Conde E, Vilchis JC: Perivascular epithelioid cell tumor of abdominal origin. Ann Diagn Pathol; 2010 Jun;14(3):173-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Perivascular epithelioid cell tumor of abdominal origin.
  • Perivascular epithelioid tumor is not a common disease; therefore, large series are not available in the literature, and most are case reports.
  • Histologic characteristics of these neoplasms are positivity to melanogenic (HMB-45) and muscle stains.
  • All these neoplasms have the characteristic perivascular epithelioid cell or "PEC," but the term myomelanocyte tumor has been proposed because of the immunohistochemistry expression.
  • We report 3 cases of abdominal PEComa, 1 of them with benign clinical outcome and 2 with an aggressive behavior.
  • [MeSH-major] Epithelioid Cells / pathology. Pelvic Neoplasms / pathology. Perivascular Epithelioid Cell Neoplasms / secondary
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / metabolism. Combined Modality Therapy. Fatal Outcome. Female. Humans. Immunohistochemistry. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20471562.001).
  • [ISSN] 1532-8198
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


57. Dong SZ, Zhu M, Zhong YM, Yin MZ: Use of foetal MRI in diagnosing hepatic hemangioendotheliomas: a report of four cases. Eur J Radiol; 2010 Sep;75(3):301-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MRI was performed on four foetuses at 33+4, 37+4, 24 and 21+6 weeks gestation following US evaluations that demonstrated foetal abdominal tumours.
  • In each case, the foetal MRI detected an isolated vascular hepatic tumour with low T1 and inhomogeneous high T2 signal intensity.
  • Prenatal MRI may provide a useful adjunct to US in assessing foetal hepatic tumours.
  • [MeSH-major] Hemangioendothelioma / diagnosis. Liver Neoplasms / diagnosis. Magnetic Resonance Imaging / methods. Prenatal Diagnosis / methods

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Prenatal Testing.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20580504.001).
  • [ISSN] 1872-7727
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


58. Paster EV, Villines KA, Hickman DL: Endpoints for mouse abdominal tumor models: refinement of current criteria. Comp Med; 2009 Jun;59(3):234-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endpoints for mouse abdominal tumor models: refinement of current criteria.
  • Accurate, rapid, and noninvasive health assessments are required to establish more appropriate endpoints in mouse cancer models where tumor size is not easily measured.
  • We evaluated potential endpoints in mice with experimentally induced peritoneal lymphoma, an abdominal tumor model, by comparing body weight, body condition, and behavior with those of a control group of mice not developing lymphoma.
  • Our hypothesis was that body weight would increase or plateau, whereas body condition and behavioral scores would decrease, as disease progressed.
  • Our results support the use of body condition and behavioral scoring as adjunctive assessment methods for mice involved in abdominal lymphoma tumor studies in which health may decline despite an increase or plateau in body weight.
  • [MeSH-major] Behavior, Animal. Body Constitution. Disease Models, Animal. Endpoint Determination. Lymphoma, T-Cell / pathology. Peritoneal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] ILAR J. 2000;41(2):72-9 [11406700.001]
  • [Cites] Lab Anim (NY). 2001 Mar;30(3):46-9 [11385757.001]
  • [Cites] ILAR J. 2000;41(2):87-93 [11417496.001]
  • [Cites] Contemp Top Lab Anim Sci. 2002 Mar;41(2):24-7 [11958599.001]
  • [Cites] Contemp Top Lab Anim Sci. 2003 Jul;42(4):13-20 [12906396.001]
  • [Cites] J Anim Sci. 2003 Sep;81(9):2311-21 [12968707.001]
  • [Cites] Obes Rev. 2004 Feb;5(1):13-9 [14969503.001]
  • [Cites] Breast Cancer Res Treat. 1997 Nov-Dec;46(2-3):313-31 [9478283.001]
  • [Cites] Lab Anim Sci. 1999 Jun;49(3):319-23 [10403450.001]
  • [Cites] Vet Clin North Am Small Anim Pract. 2005 May;35(3):713-42 [15833567.001]
  • [Cites] Can Vet J. 2006 Feb;47(2):136-43 [16579039.001]
  • [Cites] J Anim Sci. 2006 Jul;84(7):1778-89 [16775062.001]
  • [Cites] Vet Clin North Am Small Anim Pract. 2006 Nov;36(6):1283-95, vii [17085235.001]
  • [Cites] J Anim Sci. 2007 Jul;85(7):1758-69 [17371790.001]
  • [Cites] J Feline Med Surg. 2007 Oct;9(5):411-7 [17451991.001]
  • [Cites] Neurosci Lett. 2008 May 2;436(1):13-8 [18375060.001]
  • [Cites] J Vet Intern Med. 2008 May-Jun;22(3):561-5 [18466257.001]
  • [Cites] J Anim Sci. 2008 Oct;86(10):2549-56 [18502876.001]
  • [Cites] Reprod Domest Anim. 2009 Apr;44(2):167-73 [18564311.001]
  • [Cites] ILAR J. 2000;41(2):80-6 [11406701.001]
  • (PMID = 19619413.001).
  • [ISSN] 1532-0820
  • [Journal-full-title] Comparative medicine
  • [ISO-abbreviation] Comp. Med.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2733284
  •  go-up   go-down


59. Polikarpova SB, Lyubimova NV, Smirnova EA, Britvin TA, Ogereliev AS, Davidov MI: Serum angiogenic factors in patients with neuroendocrine tumors of abdominal organs. Bull Exp Biol Med; 2009 Oct;148(4):634-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serum angiogenic factors in patients with neuroendocrine tumors of abdominal organs.
  • The initial (before treatment) levels of VEGF, endostatin, and tumor necrosis factor-beta (TNF-beta) were measured in the sera of 20 patients with malignant and benign neuroendocrine tumors of the abdominal organs and 25 healthy controls.
  • The initial levels of VEGF, endostatin, and TNF-beta in the total group of patients with neuroendocrine tumors of abdominal organs did not differ from the control.
  • A significant difference was detected between the mean serum concentrations of endostatin in patients with benign and malignant neuroendocrine tumors: 64.1+/-14.7 and 107.8+/-14.1 ng/ml, respectively (p=0.043).
  • A direct correlation between endostatin, TNF-beta concentrations and maximum size of the primary tumor was detected in patients with malignant neuroendocrine tumors.
  • Direct correlations between the initial levels of VEGF and endostatin and an inverse correlation between VEGF and TNF-beta concentrations were detected in patients with benign neuroendocrine tumors.
  • [MeSH-major] Abdominal Neoplasms. Endostatins / blood. Lymphotoxin-alpha / blood. Neuroendocrine Tumors. Vascular Endothelial Growth Factor A / blood

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20396759.001).
  • [ISSN] 1573-8221
  • [Journal-full-title] Bulletin of experimental biology and medicine
  • [ISO-abbreviation] Bull. Exp. Biol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Endostatins; 0 / Lymphotoxin-alpha; 0 / Vascular Endothelial Growth Factor A
  •  go-up   go-down


60. Dedeken P, Louw V, Vandooren AK, Verstegen G, Goossens W, Dubois B: Plumbism or lead intoxication mimicking an abdominal tumor. J Gen Intern Med; 2006 Jun;21(6):C1-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Plumbism or lead intoxication mimicking an abdominal tumor.
  • In this case report, the diagnosis was finally made when bilateral wrist drop developed on top of abdominal cramps and anemia.
  • Before, ascites raised the suspicion of a tumor.
  • Therefore, each element of the triad of unexplained anemia, abdominal cramps, and bilateral wrist (or foot) drop should lead any physician to consider the diagnosis of lead intoxication.
  • [MeSH-major] Abdominal Neoplasms / diagnosis. Lead Poisoning / diagnosis. Lead Poisoning, Nervous System / diagnosis

  • MedlinePlus Health Information. consumer health - Lead Poisoning.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Succimer .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Clin Pharmacol. 2002 May;53(5):451-8 [11994050.001]
  • [Cites] West J Med. 1994 Aug;161(2):153-9 [7941534.001]
  • [Cites] JAMA. 1989 Jul 28;262(4):532-4 [2661879.001]
  • [Cites] J Clin Invest. 1976 Aug;58(2):260-70 [783195.001]
  • (PMID = 16808730.001).
  • [ISSN] 1525-1497
  • [Journal-full-title] Journal of general internal medicine
  • [ISO-abbreviation] J Gen Intern Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chelating Agents; 0 / Protoporphyrins; DX1U2629QE / Succimer
  • [Other-IDs] NLM/ PMC1924641
  •  go-up   go-down


61. Bausch B, Boedeker CC, Berlis A, Brink I, Cybulla M, Walz MK, Januszewicz A, Letizia C, Opocher G, Eng C, Neumann HP: Genetic and clinical investigation of pheochromocytoma: a 22-year experience, from Freiburg, Germany to international effort. Ann N Y Acad Sci; 2006 Aug;1073:122-37
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Major clinical steps are the prospective study on hormone tests and imaging techniques for adrenal and extra-adrenal abdominal tumors as well as the concept of organ sparing and endoscopic tumor resection.
  • [MeSH-major] Adrenal Gland Neoplasms / genetics. Adrenal Gland Neoplasms / pathology. Pheochromocytoma / genetics. Pheochromocytoma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Genetic Predisposition to Disease. Germ-Line Mutation. Germany. Humans. Infant. Male. Middle Aged. Succinate Dehydrogenase / genetics

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17102079.001).
  • [ISSN] 0077-8923
  • [Journal-full-title] Annals of the New York Academy of Sciences
  • [ISO-abbreviation] Ann. N. Y. Acad. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 1.3.99.1 / Succinate Dehydrogenase
  •  go-up   go-down


62. Heerema-McKenney A, Leuschner I, Smith N, Sennesh J, Finegold MJ: Nested stromal epithelial tumor of the liver: six cases of a distinctive pediatric neoplasm with frequent calcifications and association with cushing syndrome. Am J Surg Pathol; 2005 Jan;29(1):10-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nested stromal epithelial tumor of the liver: six cases of a distinctive pediatric neoplasm with frequent calcifications and association with cushing syndrome.
  • Rare cases of nonhepatocytic mixed stromal and epithelial tumors of the liver with associated calcification and ossification have been described previously.
  • All tumors presented as a solitary liver mass with no extrahepatic involvement.
  • Two adolescent females with palpable abdominal tumors presented with Cushing syndrome that abated after excision of the tumors.
  • The other children had tumors identified incidentally on imaging studies or at laparotomy.
  • All tumors were well circumscribed, ranging in size from 4.0 to 30.0 cm in greatest diameter.
  • The 1 patient whose tumor had sheet-like overgrowth of the nested cell population had a local recurrence with multiple hepatic nodules 1 year following the original resection.
  • A 2-year-old patient has been subsequently diagnosed with nephroblastomatosis and Wilms tumor of the kidney.
  • Follow-up information was available in an additional 3 patients with no tumor recurrence or metastatic disease at 2, 3, and 14 years.
  • [MeSH-major] Epithelial Cells / pathology. Liver Neoplasms / pathology. Neoplasms, Complex and Mixed / pathology. Stromal Cells / pathology
  • [MeSH-minor] Adolescent. Adrenocorticotropic Hormone / metabolism. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biomarkers, Tumor / metabolism. Child. Child, Preschool. Diagnosis, Differential. Disease-Free Survival. Female. Hepatectomy. Humans. Immunoenzyme Techniques. Male. Sarcoma, Synovial / diagnosis

  • Genetic Alliance. consumer health - Cushing's Syndrome.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. Corticotropin .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15613852.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 9002-60-2 / Adrenocorticotropic Hormone
  •  go-up   go-down


63. Suzuki N, Yoshino S, Somura H, Ueno T, Oka M: [A case of rapid growth GIST successfully treated with resection after long-term use of imatinib]. Gan To Kagaku Ryoho; 2009 Nov;36(12):2354-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a case of rapid growth GIST successfully treated with resection, which imatinib controlled it as a stable disease for three years.
  • A 68-year-old woman underwent simple hysterectomy and bilateral oophorectomy for the pelvic tumor.
  • After diagnosed as high risk GIST, the patient was treated with imatinib at a dose of 400 mg/day, and the tumor was controlled as a stable disease for 3 years.
  • At the end of 2008, lower abdominal tumor grew rapidly and intra-abdominal hemorrhage appeared.
  • Although sunitinib was administered at a dose of 37.5 mg/day, the tumor was enlarged, and sunitinib was stopped because the patient developed grade 3 diarrhea.
  • IVR was tried to control abdominal hemorrhage, but it was unsuccessful.
  • In January 2009, the resection of main tumor was performed to control abdominal hemorrhage.
  • [MeSH-major] Abdominal Neoplasms / therapy. Antineoplastic Agents / therapeutic use. Gastrointestinal Stromal Tumors / therapy. Piperazines / therapeutic use. Pyrimidines / therapeutic use

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • Hazardous Substances Data Bank. IMATINIB MESYLATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20037420.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate
  •  go-up   go-down


64. Castillo O, Frisancho O, Contardo C, Morales D, Garatea R: [Gastrointestinal stromal tumor (GIST) of Duodenum: Case report]. Rev Gastroenterol Peru; 2010 Jul-Sep;30(3):241-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Gastrointestinal stromal tumor (GIST) of Duodenum: Case report].
  • [Transliterated title] Tumor estromal gastrointestinal en duodeno.
  • During that hospitalization, it was found a duodenal tumor by tomography; however, no further studies or follow up on this finding was done.
  • She presented with fever, abdominal pain and a palpable abdominal tumor in the right upper quadrant for a month.
  • We realized a three-phase multislice spiral tomography with pancreatic curved reconstruction, which allowed to identified an ovoid tumor of 80 x 60 mm, with an area of central necrosis and intense contrast enhancement (arterial phase), located between the second and third duodenal portion, near the head of the pancreas.
  • The patient underwent tumor resection without complication and the histologic diagnosis of the surgical specimen revealed a duodenal stromal tumor (GIST) with extraluminal transmural growth.
  • We presented this case because of its unusual presentation of this tumor.
  • [MeSH-major] Duodenal Neoplasms. Gastrointestinal Stromal Tumors

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Rev Gastroenterol Peru. 2010 Oct-Dec;30(4):373
  • (PMID = 20924435.001).
  • [ISSN] 1022-5129
  • [Journal-full-title] Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú
  • [ISO-abbreviation] Rev Gastroenterol Peru
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Peru
  •  go-up   go-down


65. Ohwada S, Hamada K, Kawate S, Sunose Y, Tomizawa N, Yamada T, Okabe T, Ogawa T, Sato Y: Left renal vein graft for vascular reconstruction in abdominal malignancy. World J Surg; 2007 Jun;31(6):1215-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Left renal vein graft for vascular reconstruction in abdominal malignancy.
  • BACKGROUND: Advanced abdominal malignancies are occasionally invasive for the major blood vessels, such as the portal vein (PV), inferior vena cava (IVC), and major hepatic veins (HVs), and complete removal of the tumors is required for patients undergoing vascular resection and reconstruction.
  • METHODS: A total of 113 patients underwent vascular resection including the PV (42 patients), IVC (68 patients), and HV (3 patients) for hepatobiliary-pancreatic or abdominal tumor resection.
  • [MeSH-major] Abdominal Neoplasms / surgery. Portal Vein / surgery. Veins / transplantation. Vena Cava, Inferior / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Bile Duct Neoplasms / mortality. Bile Duct Neoplasms / pathology. Bile Duct Neoplasms / surgery. Bile Ducts, Intrahepatic / pathology. Bile Ducts, Intrahepatic / surgery. Carcinoma, Hepatocellular / mortality. Carcinoma, Hepatocellular / pathology. Carcinoma, Hepatocellular / surgery. Carcinoma, Renal Cell / mortality. Carcinoma, Renal Cell / pathology. Carcinoma, Renal Cell / surgery. Cholangiocarcinoma / mortality. Cholangiocarcinoma / pathology. Cholangiocarcinoma / surgery. Female. Follow-Up Studies. Hepatectomy. Hospital Mortality. Humans. Kidney Neoplasms / mortality. Kidney Neoplasms / pathology. Kidney Neoplasms / surgery. Liver Neoplasms / mortality. Liver Neoplasms / pathology. Liver Neoplasms / secondary. Liver Neoplasms / surgery. Male. Microsurgery. Middle Aged. Neoplasm Invasiveness. Pancreatic Neoplasms / mortality. Pancreatic Neoplasms / pathology. Pancreatic Neoplasms / surgery. Pancreaticoduodenectomy. Postoperative Complications / mortality. Tomography, X-Ray Computed. Vascular Patency / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Liver Transpl. 2006 Aug;12(8):1233-6 [16724339.001]
  • [Cites] J Am Coll Surg. 1995 Apr;180(4):497-8 [7719560.001]
  • [Cites] Ann Surg. 2002 Aug;236(2):241-7 [12170030.001]
  • [Cites] J Gastrointest Surg. 2005 Mar;9(3):353-6 [15749595.001]
  • [Cites] J Am Coll Surg. 2006 Jan;202(1):87-92 [16377501.001]
  • [Cites] World J Surg. 2000 Mar;24(3):377-82 [10658076.001]
  • [Cites] Langenbecks Arch Surg. 2004 Apr;389(2):110-3 [15004752.001]
  • [Cites] Am J Transplant. 2005 Jun;5(6):1339-46 [15888039.001]
  • [Cites] Surg Today. 1995;25(4):378-80 [7633133.001]
  • [Cites] Hepatogastroenterology. 1998 Sep-Oct;45(23):1833-6 [9840158.001]
  • [Cites] Hepatogastroenterology. 1997 Nov-Dec;44(18):1619-23 [9427033.001]
  • [Cites] Hepatogastroenterology. 2006 Jul-Aug;53(70):479-83 [16995445.001]
  • [Cites] Arch Surg. 1990 Nov;125(11):1455-9 [2241557.001]
  • [Cites] Ann Surg. 2002 Jun;235(6):850-8 [12035042.001]
  • [Cites] J Am Coll Surg. 1999 Jan;188(1):63-71 [9915245.001]
  • [Cites] Surgery. 1990 Nov;108(5):913-8 [2237772.001]
  • [Cites] Hepatogastroenterology. 1999 Mar-Apr;46(26):1151-5 [10370683.001]
  • [Cites] J Surg Oncol. 2006 Mar 15;93(4):338-42 [16496372.001]
  • [Cites] J Nephrol. 2002 Mar-Apr;15(2):186-90 [12018637.001]
  • [Cites] AJR Am J Roentgenol. 1982 Oct;139(4):703-9 [6981932.001]
  • [Cites] Radiology. 1995 Nov;197(2):351-6 [7480676.001]
  • [Cites] Hepatogastroenterology. 2004 Nov-Dec;51(60):1581-5 [15532782.001]
  • [Cites] Hepatogastroenterology. 1999 May-Jun;46(27):1823-6 [10430353.001]
  • [Cites] Surgery. 1993 Jul;114(1):59-64 [8356528.001]
  • (PMID = 17453283.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


66. Till H, Schmidt H: Juvenile granulosa cell tumour (JGCT) of the ovary in a 6-year-old girl: laparoscopic resection achieves long-term oncological success. Eur J Pediatr Surg; 2005 Aug;15(4):292-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Juvenile granulosa cell tumour (JGCT) of the ovary in a 6-year-old girl: laparoscopic resection achieves long-term oncological success.
  • Juvenile granulosa cell tumours (JGCT) represent a rare malignancy in childhood and their laparoscopic resection has not been advocated yet.
  • We report on a 6-year-old girl with signs of precocious pseudo-puberty and an abdominal tumour.
  • Work-up revealed premature thelarche, vaginal discharge, elevated estrogen levels, and a solid tumour in the lower pelvis (6 x 4 x 3 cm in MRI).
  • The girl underwent laparoscopy (3 ports, 5-mm instruments), during which a non-invasive, mobile tumour of the left ovary was found.
  • Within 3 months postoperatively the girl's signs of precocious puberty had resolved and at present, after a follow-up of more than 3 years, there is no evidence of tumour recurrence.
  • Minimally invasive surgery of solid ovarian tumours in children remains controversial.
  • [MeSH-major] Granulosa Cell Tumor / surgery. Laparoscopy. Ovarian Neoplasms / surgery
  • [MeSH-minor] Abdominal Pain / etiology. Child. Female. Humans. Magnetic Resonance Imaging. Puberty, Precocious / etiology. Recurrence

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16163598.001).
  • [ISSN] 0939-7248
  • [Journal-full-title] European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift für Kinderchirurgie
  • [ISO-abbreviation] Eur J Pediatr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


67. Yoshimura N, Ohara H, Miyabe K, Ban T, Sano H, Naitoh I, Hayashi K, Ando T, Nakazawa T, Joh T: A case of gastrointestinal stromal tumor with spontaneous rupture in the greater omentum. Int Semin Surg Oncol; 2008;5:19
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of gastrointestinal stromal tumor with spontaneous rupture in the greater omentum.
  • BACKGROUND: Although GIST generally occurs in the digestive tract, such as the stomach, and small and small intestine primarily, Omental GIST tumours are very rare.
  • CASE PRESENTATION: A 63-year-old male patient, who recognized an abdominal tumor 1 year before admission, had a slight expansion of the tumor, reduction of the body and malaise, was consulted to our hospital.
  • Abdominal CT and MRI revealed a cystic lesion of 26 cm in diameter with a clear boundary from immediately below the interseptum to the pelvic cavity, and imaged the septum and cystic wall.
  • We considered that the patient had a cystic tumor in the abdomen, of which the primary lesion was unknown, and scheduled surgery.
  • The patient unfortunately deteriorated with shock and sudden pain in the abdomen.
  • Wediagnosed tumor rapture, and emergency surgery was performed.
  • The tumor, weighing 3,600 g, was mostly cystic, and filled with sanguinous fluid and clot.
  • Histologically, the tumor was composed of spindle cells, and was positive for c-KIT (CD117), slightly positive for alpha-smooth muscle actin (SMA), and S-100 protein positive.
  • Based on these findings, the tumor was diagnosed as GIST primarily occurring in the greater omentum.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1999 Sep;23(9):1109-18 [10478672.001]
  • [Cites] Ann Surg. 2000 Jan;231(1):51-8 [10636102.001]
  • [Cites] Pathol Int. 2001 Jul;51(7):524-31 [11472565.001]
  • [Cites] Science. 1998 Jan 23;279(5350):577-80 [9438854.001]
  • (PMID = 18664259.001).
  • [ISSN] 1477-7800
  • [Journal-full-title] International seminars in surgical oncology : ISSO
  • [ISO-abbreviation] Int Semin Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2515846
  •  go-up   go-down


68. Predescu D, Gheorghe M, Predoiu I, Iosif C, Constantin A, Chiru F, Cociu L, Constantinoiu S: [Gastrointestinal stromal tumor (GIST)--medical rarities?]. Chirurgia (Bucur); 2010 Jul-Aug;105(4):577-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Gastrointestinal stromal tumor (GIST)--medical rarities?].
  • Although their overall incidence is low, GISTs are distinctive subgroup of gastrointestinal mesenchymal tumors which express CD117 or platelet derived growth factor receptor alpha (PDGFRA).
  • Considered as rare digestive cancers, tumors like schwannomas, neurofibromas, gastrointestinal leiomiomas are now reclassified as GIST based on immunohistochemistry studies.
  • Most with symptomatic disease: palpable tumor, abdominal pain, anemia, fatigue, superior digestive hemorrhage or occlusion.
  • Imagistic diagnosis consisted of: barium swallow, abdominal sonography, CT and PET-CT.
  • The principle of surgery for GIST is RO resection of the tumor.
  • Tumor rupture or R1 resection of the primary tumor has a negative impact on disease free survival.
  • Some patients (great volume tumors, R1 or R2 resection) had adjuvant treatment.
  • [MeSH-major] Duodenal Neoplasms. Gastrointestinal Stromal Tumors. Ileal Neoplasms. Jejunal Neoplasms. Neoplasm Recurrence, Local. Stomach Neoplasms


69. Piette C, Dresse MF, Forget P, Schmitz V, Demarche M, Erpicum P, Closon MT, Rutten I, Paulus P, Vivegnis D, Beguin Y, Jamblin P, Hoyoux C: [Clinical evaluation of 23 children with neuroblastoma. The experience of a single institution]. Rev Med Liege; 2005 Mar;60(3):173-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Les neuroblastomes de l'enfant. A propos de 23 cas.
  • Half of them were less than 2 years of age; in 19 of 23, the primitive tumour was abdominal; 35% of them were initially metastatic.
  • Pronostic factors are age, extension of the disease at diagnosis, biologic parameters and genetic study of the neuroblast cells (amplification of N-myc oncogen).
  • [MeSH-minor] Abdominal Neoplasms / diagnosis. Abdominal Neoplasms / genetics. Abdominal Neoplasms / therapy. Child. Child, Preschool. Female. Humans. Infant. Infant, Newborn. Male. Retrospective Studies. Thoracic Neoplasms / diagnosis. Thoracic Neoplasms / genetics. Thoracic Neoplasms / therapy

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • ORBi (University of Liege). Free full Text at ORBi .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15884700.001).
  • [ISSN] 0370-629X
  • [Journal-full-title] Revue médicale de Liège
  • [ISO-abbreviation] Rev Med Liege
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


70. Risum S, Høgdall C, Loft A, Berthelsen AK, Høgdall E, Nedergaard L, Lundvall L, Engelholm SA: Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? Gynecol Oncol; 2010 Mar;116(3):395-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: From September 2004 to August 2007, 201 patients with a Risk of Malignancy Index (RMI) >150 based on serum CA-125, ultrasound examinations and menopausal state, underwent PET/CT within 2 weeks prior to standard surgery/debulking of a pelvic tumor.
  • RESULTS: Median follow-up was 30.2 months; median age was 62.5 years (range 35-85 years); 97% (64/66) had a performance status <or=2; 38% (25/66) underwent complete debulking (no macroscopic residual tumor); 51% (39/66) was diagnosed with PET/CT stage III and 41% (27/66) was diagnosed with PET/CT stage IV.
  • Using univariate analysis, PET/CT stage III (P=0.03), complete debulking (no macroscopic residual tumor) (P=0.002), and GOG performance status <or=2 (P=0.04) were statistically significant prognostic variables.
  • The strongest determinant of patient outcome is residual abdominal tumor after primary surgery.
  • [MeSH-major] Fluorodeoxyglucose F18. Ovarian Neoplasms / radionuclide imaging. Positron-Emission Tomography / methods. Radiopharmaceuticals
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. CA-125 Antigen / blood. Female. Humans. Middle Aged. Neoplasm Staging. Prognosis. Prospective Studies. Survival Rate

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20042226.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CA-125 Antigen; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


71. Culp WT, Weisse C, Kellogg ME, Gordon IK, Clarke DL, May LR, Drobatz KJ: Spontaneous hemoperitoneum in cats: 65 cases (1994-2006). J Am Vet Med Assoc; 2010 May 1;236(9):978-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Forty-six percent (30/65) of cats had abdominal neoplasia, and 54% (35/65) had nonneoplastic conditions.
  • Hemangiosarcoma was the most often diagnosed neoplasm (18/30; 60%), and the spleen was the most common location for neoplasia (11/30; 37%).
  • Cats with neoplasia were significantly older and had significantly lower PCVs than cats with non-neoplastic disease.
  • [MeSH-minor] Animals. Cats. Female. Male. Neoplasms / complications. Neoplasms / veterinary. Prognosis. Wounds and Injuries / complications. Wounds and Injuries / veterinary

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20433398.001).
  • [ISSN] 0003-1488
  • [Journal-full-title] Journal of the American Veterinary Medical Association
  • [ISO-abbreviation] J. Am. Vet. Med. Assoc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Izumi H, Dowaki S, Matsuyama M, Yazawa N, Tobita K, Imaizumi T, Makuuchi H: [Retroperitoneal liposarcoma: a case report]. Nihon Shokakibyo Gakkai Zasshi; 2010 Sep;107(9):1505-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 35-year-old woman who had visited an other hospital because of epigastralgia and anorexia was found to have a giant abdominal tumor, and was referred to our hospital.
  • On admission, the abdomen was markedly distended.
  • Abdominal CT scan and MRI showed the presence of a retroperitoneal tumor which occupied almost the entire abdominal cavity.
  • The tumor was located between the subphrenic space and the pelvic cavity, and was compressing the stomach, duodenum, pancreas and colon.
  • Removal of the retroperitoneal tumor, including the right kidney, was performed.
  • The resected tumor was 34 × 28 × 20 cm, weighed 5.5 kg and showed a variety of finding.
  • [MeSH-major] Liposarcoma / pathology. Retroperitoneal Neoplasms / pathology

  • Genetic Alliance. consumer health - Liposarcoma.
  • Genetic Alliance. consumer health - Retroperitoneal liposarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20827048.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  •  go-up   go-down


73. Bode HH, Schimana W, Swai B, Bode U: Sexual precocity associated with an abdominal tumor in an African boy. J Pediatr Endocrinol Metab; 2008 Mar;21(3):275-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sexual precocity associated with an abdominal tumor in an African boy.
  • We report a 3 year-old boy in Tanzania with an abdominal mass and isosexual precocity due to an hCG-secreting hepatoblastoma.
  • [MeSH-major] Hepatoblastoma / pathology. Liver Neoplasms / pathology. Puberty, Precocious / etiology

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18540255.001).
  • [ISSN] 0334-018X
  • [Journal-full-title] Journal of pediatric endocrinology & metabolism : JPEM
  • [ISO-abbreviation] J. Pediatr. Endocrinol. Metab.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Chorionic Gonadotropin; 0 / alpha-Fetoproteins; 0 / beta Catenin; 6PLQ3CP4P3 / Etoposide; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


74. Noda Y, Fujita N, Kobayashi G, Itoh K, Horaguchi J, Takasawa O, Obana T, Koshita S, Kanno Y, Suzuki T, Hirasawa D, Sugawara T, Ohira T, Harada Y, Tsuchiya T, Sawai T, Uzuki M, Kurose A: Diagnostic efficacy of the cell block method in comparison with smear cytology of tissue samples obtained by endoscopic ultrasound-guided fine-needle aspiration. J Gastroenterol; 2010 Aug;45(8):868-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We prospectively evaluated the diagnostic efficacy of the cell block (CB) method and that of smear cytology using tissue samples obtained in the same needle pass at EUS-FNA in 33 patients with pancreatic tumors, abdominal tumors or swollen lymph nodes.
  • [MeSH-major] Abdominal Neoplasms / diagnosis. Endoscopy / methods. Lymph Nodes / pathology. Pancreatic Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gastrointest Endosc. 2004 Sep;60(3):378-84 [15332027.001]
  • [Cites] Gastrointest Endosc. 2005 Apr;61(4):610-1 [15812422.001]
  • [Cites] Gastrointest Endosc. 1997 May;45(5):387-93 [9165320.001]
  • [Cites] Diagn Cytopathol. 1997 Oct;17(4):239-47 [9316777.001]
  • [Cites] Gastrointest Endosc. 2002 Dec;56(6):868-72 [12447300.001]
  • [Cites] JOP. 2008 Jul 10;9(4):422-30 [18648133.001]
  • [Cites] Gastrointest Endosc. 2008 Jan;67(1):28-34 [18155422.001]
  • [Cites] Gastrointest Endosc. 2005 Jun;61(7):854-61 [15933687.001]
  • [Cites] Acta Gastroenterol Latinoam. 2008 Dec;38(4):246-51 [19157379.001]
  • [Cites] Gastrointest Endosc. 2000 Feb;51(2):184-90 [10650262.001]
  • [Cites] Gastrointest Endosc. 2008 Aug;68(2):237-42; quiz 334, 335 [18423464.001]
  • [Cites] Endoscopy. 2006 Sep;38(9):919-24 [16981110.001]
  • [Cites] Connect Tissue Res. 1989;19(2-4):277-97 [2805684.001]
  • [Cites] Gastrointest Endosc. 2008 May;67(6):988-90 [18279861.001]
  • [Cites] Cancer. 2003 Dec 25;99(6):365-71 [14681945.001]
  • [Cites] Am J Gastroenterol. 2003 Jun;98(6):1289-94 [12818271.001]
  • [Cites] Stain Technol. 1986 Jul;61(4):235-8 [3750354.001]
  • [Cites] Gastrointest Endosc. 2006 Oct;64(4):505-11 [16996340.001]
  • [Cites] Gastrointest Endosc. 2005 Jan;61(1):8-12 [15672049.001]
  • [Cites] Cancer. 2001 Oct 25;93(5):319-22 [11668466.001]
  • [Cites] Gastrointest Endosc. 2001 Oct;54(4):441-7 [11577304.001]
  • (PMID = 20177713.001).
  • [ISSN] 1435-5922
  • [Journal-full-title] Journal of gastroenterology
  • [ISO-abbreviation] J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


75. Kothary N, Dieterich S, Louie JD, Koong AC, Hofmann LV, Sze DY: A primer on image-guided radiation therapy for the interventional radiologist. J Vasc Interv Radiol; 2009 Jul;20(7):859-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The use of image-guided radiation therapy in thoracic and abdominal tumors is increasing.
  • [MeSH-major] Diagnostic Imaging / methods. Neoplasms / radiography. Neoplasms / radiotherapy. Radiography, Interventional / methods. Radiotherapy, Computer-Assisted / methods. Radiotherapy, Conformal / methods

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19481470.001).
  • [ISSN] 1535-7732
  • [Journal-full-title] Journal of vascular and interventional radiology : JVIR
  • [ISO-abbreviation] J Vasc Interv Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 18
  •  go-up   go-down


76. Carrafiello G, Laganà D, Ianniello A, Dionigi G, Novario R, Recaldini C, Mangini M, Cuffari S, Fugazzola C: Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol; 2007 Dec;51(6):550-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works.
  • We carried out an internal review board-approved prospective study of the delayed symptoms that occurred after 71 consecutive RFA sessions in 53 patients (12 women and 41 men; age range 45-83 years; mean age 71.6 years) with 45 primary liver tumours, 34 liver metastases, 3 renal cell carcinoma (RCC), 2 residual lesions from RCC after nephrectomy and 1 pancreatic metastases from RCC.
  • Postablation syndrome is a common phenomenon after RFA of solid abdominal tumours.
  • [MeSH-major] Catheter Ablation / adverse effects. Kidney Neoplasms / surgery. Liver Neoplasms / surgery. Pancreatic Neoplasms / surgery. Radiography, Interventional
  • [MeSH-minor] Aged. Aged, 80 and over. Carcinoma, Renal Cell / pathology. Carcinoma, Renal Cell / surgery. Chi-Square Distribution. Female. Humans. Male. Middle Aged. Neoplasm, Residual / surgery. Prospective Studies. Syndrome

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17958690.001).
  • [ISSN] 0004-8461
  • [Journal-full-title] Australasian radiology
  • [ISO-abbreviation] Australas Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Australia
  • [Number-of-references] 33
  •  go-up   go-down


77. Onishi H, Kawakami H, Marino K, Komiyama T, Kuriyama K, Araya M, Saito R, Aoki S, Araki T: A simple respiratory indicator for irradiation during voluntary breath holding: a one-touch device without electronic materials. Radiology; 2010 Jun;255(3):917-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIALS AND METHODS: Evaluation was performed of a respiratory monitoring device that enables determination of the respiratory level in a patient by measuring the movement of two contacts on the abdomen and chest wall.
  • The initial study group comprised 21 consecutive patients (15 men, six women; mean age, 75 years; range, 56-92 years) with lung or abdominal tumors who underwent examination with the device and computed tomography (CT) for three-dimensional reproducibility of lung base position during voluntary breath holding with or without use of the device.
  • [MeSH-major] Abdominal Neoplasms / radiography. Abdominal Neoplasms / radiotherapy. Lung Neoplasms / radiography. Lung Neoplasms / radiotherapy. Monitoring, Physiologic / instrumentation. Tomography, X-Ray Computed
  • [MeSH-minor] Abdomen / physiology. Aged. Aged, 80 and over. Equipment Design. Female. Humans. Male. Middle Aged. Movement. Posture / physiology. Reproducibility of Results. Respiration. Thoracic Wall / physiology. Whole Body Imaging

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright RSNA, 2010
  • (PMID = 20501729.001).
  • [ISSN] 1527-1315
  • [Journal-full-title] Radiology
  • [ISO-abbreviation] Radiology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


78. Kim CK, Park BK, Choi JY, Kim BG, Han H: Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT. J Comput Assist Tomogr; 2007 Nov-Dec;31(6):868-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To compare the diagnostic performances of magnetic resonance imaging (MRI) and positron emission tomography/computed tomography (PET/CT) for the detection of recurrent ovarian tumor.
  • METHODS: Thirty-six patients who underwent primary cytoreductive surgery for ovarian carcinoma received both MRI and PET/CT for the evaluation of ovarian tumor recurrence.
  • Recurrent ovarian tumors in abdomen and pelvis were classified based on site as follows:.
  • Patient-based and lesion-based analyses were retrospectively performed with the aim of detecting tumor recurrence.
  • For the detection of recurrent ovarian tumors, we compared patient-based and lesion-based diagnostic accuracies of these 2 modalities using the McNemar test.
  • RESULTS: Histopathologic, clinical, and radiological follow-up findings revealed recurrent ovarian tumors in 35 sites of 22 patients.
  • These 35 sites consisted of local pelvic recurrence (n = 15), peritoneal lesions (n = 14), lymph nodal metastasis (n = 4), and abdominal wall metastasis (n = 2).
  • In detecting recurrent ovarian tumor, patient-based sensitivity and the accuracy of PET/CT and MRI were 73% and 91% (P < 0.05), and 81% and 89% (P > 0.05), respectively.
  • CONCLUSIONS: Magnetic resonance imaging is more sensitive than PET/CT for detecting local pelvic recurrence and peritoneal lesions of recurrent ovarian tumors.
  • [MeSH-major] Magnetic Resonance Imaging. Neoplasm Recurrence, Local / diagnosis. Ovarian Neoplasms / diagnosis. Positron-Emission Tomography. Tomography, X-Ray Computed
  • [MeSH-minor] Abdominal Neoplasms / secondary. Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cystadenocarcinoma, Papillary / diagnosis. Cystadenocarcinoma, Papillary / radionuclide imaging. Female. Fluorodeoxyglucose F18. Follow-Up Studies. Humans. Image Processing, Computer-Assisted / methods. Lymphatic Metastasis / diagnosis. Lymphatic Metastasis / radionuclide imaging. Middle Aged. Neoadjuvant Therapy. Neoplasm Invasiveness. Peritoneal Neoplasms / diagnosis. Peritoneal Neoplasms / radionuclide imaging. Radiopharmaceuticals. Retrospective Studies. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18043348.001).
  • [ISSN] 0363-8715
  • [Journal-full-title] Journal of computer assisted tomography
  • [ISO-abbreviation] J Comput Assist Tomogr
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


79. Beltran Gárate B, Morales Luna D, Quiñones Avila P, Hurtado de Mendoza F, Riva Gonzales L, Yabar A, Portugal Meza K: [Primary colorectal lymphoma of diffuse large B-cells: an experience at a general hospital]. Rev Gastroenterol Peru; 2008 Jul-Sep;28(3):235-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Linfoma de células grandes B difuso primario colorectal: experiencia en un hospital general.
  • Primary colorectal lymphoma is a very rare disease.
  • The most frequent signs and symptoms were abdominal pain (78%), diarrhea (49%) and abdominal tumor (35%).
  • [MeSH-major] Colorectal Neoplasms. Lymphoma, Large B-Cell, Diffuse
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cecum / pathology. Colon / pathology. Cyclophosphamide / therapeutic use. Doxorubicin / therapeutic use. Female. Humans. Male. Middle Aged. Neoplasm Staging. Prednisone / therapeutic use. Rectum / pathology. Retrospective Studies. Time Factors. Vincristine / therapeutic use

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18958138.001).
  • [ISSN] 1022-5129
  • [Journal-full-title] Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú
  • [ISO-abbreviation] Rev Gastroenterol Peru
  • [Language] spa
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Peru
  • [Chemical-registry-number] 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


80. Cliby WA, Aletti GD, Wilson TO, Podratz KC: Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol; 2006 Dec;103(3):797-801
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Stage IIIC epithelial ovarian cancer is generally associated with upper abdominal tumor implants of greater than 2 cm and carries a grave prognosis.
  • METHODS: All consecutive patients found to have Stage IIIC epithelial ovarian cancer during a 9-year period (1994-2002) were analyzed for surgical procedures, pathology, and disease-free (DFS) and overall survival (OS).
  • Nine had small volume upper abdominal disease (IIIA/B before upstaging), 15 had disease limited to the pelvis and 12 had disease confined to the ovaries.
  • 32/36 patients had no gross residual disease at the conclusion of surgery.
  • We observed no significant difference in outcomes between patients upstaged from IIIA/B versus I-II stage disease.
  • The outcomes were superior to a control group of patients cytoreduced to either no gross RD or RD<1 cm, who had large volume upper abdominal disease at beginning of surgery (p<0.001).
  • CONCLUSIONS: Patients upstaged to Stage IIIC epithelial ovarian cancer for node involvement have an excellent 5-year OS relative to all patients with Stage IIIC disease.
  • These data demonstrate the necessity for stratifying patients classified as having Stage IIIC disease based solely on nodal disease when comparing outcomes.
  • [MeSH-major] Benchmarking. Neoplasm Staging. Neoplasms, Glandular and Epithelial / pathology. Ovarian Neoplasms / pathology. Sentinel Lymph Node Biopsy / standards
  • [MeSH-minor] Adult. Aged. Aorta, Thoracic / parasitology. Disease-Free Survival. Female. Humans. Lymph Nodes / pathology. Medical Records. Middle Aged. Minnesota / epidemiology. Pelvis / pathology. Prognosis. Registries. Retrospective Studies. Survival Analysis


81. Halpin VJ, Underwood RA, Ye D, Cooper DH, Wright M, Hickerson SM, Connett WC, Connett JM, Fleshman JW: Pneumoperitoneum does not influence trocar site implantation during tumor manipulation in a solid tumor model. Surg Endosc; 2005 Dec;19(12):1636-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pneumoperitoneum does not influence trocar site implantation during tumor manipulation in a solid tumor model.
  • BACKGROUND: The purpose of this study was to assess tumor implantation at abdominal wound sites following manipulation of a solid abdominal tumor.
  • At 2 weeks, an omental tumor was harvested and animals were randomized to bivalve (A), crush (B), strip (C), or excision (D), with or without pneumoperitoneum.
  • Four 5-mm trocars were inserted into the abdomen, and the tumor was reinserted through the midline, swept through four quadrants, and removed.
  • Tumor implantation at wound sites was documented at 7 weeks.
  • CONCLUSIONS: Tumor implantation at trocar sites is due to spillage of tumor during manipulation and not to pneumoperitoneum.
  • [MeSH-major] Colonic Neoplasms / secondary. Colonic Neoplasms / surgery. Laparoscopy / adverse effects. Neoplasm Seeding. Pneumoperitoneum, Artificial / adverse effects
  • [MeSH-minor] Animals. Cell Line, Tumor. Cricetinae. Humans. Laparoscopes. Male. Mesocricetus. Neoplasm Transplantation

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Surg. 1995 Mar;82(3):295-8 [7795990.001]
  • [Cites] N Engl J Med. 2004 May 13;350(20):2050-9 [15141043.001]
  • [Cites] Dis Colon Rectum. 1995 Nov;38(11):1182-8 [7587761.001]
  • [Cites] Br J Surg. 1994 May;81(5):648-52 [8044537.001]
  • [Cites] Dis Colon Rectum. 1993 Sep;36(9):858-61 [8397078.001]
  • [Cites] Int J Cancer. 1983 May 15;31(5):543-52 [6852972.001]
  • [Cites] Lancet. 1993 Jan 23;341(8839):249-50 [8093539.001]
  • [Cites] Dis Colon Rectum. 1998 Feb;41(2):141-6 [9556235.001]
  • [Cites] Dis Colon Rectum. 1996 Feb;39(2):200-7 [8620788.001]
  • [Cites] Surgery. 1997 Jul;122(1):1-7 [9225907.001]
  • [Cites] Surg Endosc. 1994 Jun;8(6):698-701 [8059312.001]
  • (PMID = 16211435.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


82. Obradovic V, Artiko V, Petrovic M, Lausevic Z, Stojkovic M, Sobic-Saranovic D, Petrovic N, Vlajkovic M, Krivokapic Z: Radioimmunoscintigraphy of colorectal carcinomas with three different radiopharmaceuticals. Neoplasma; 2006;53(5):444-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Other imaging methods (CT, US, MRI) have advantage in detection of liver metastases, while immunoscintigraphy is more specific for the assessment of reccurences of the abdominal tumors.
  • [MeSH-major] Adenocarcinoma / radionuclide imaging. Colorectal Neoplasms / radionuclide imaging. Neoplasm Metastasis / radionuclide imaging. Neoplasm Recurrence, Local / radionuclide imaging. Radioimmunodetection / methods. Radiopharmaceuticals

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17013541.001).
  • [ISSN] 0028-2685
  • [Journal-full-title] Neoplasma
  • [ISO-abbreviation] Neoplasma
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Slovakia
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Imacis-1; 0 / Indium Radioisotopes; 0 / Radiopharmaceuticals
  •  go-up   go-down


83. Miyake M, Tateishi U, Maeda T, Arai Y, Seki K, Hasegawa T, Sugimura K: A case of ganglioneuroma presenting abnormal FDG uptake. Ann Nucl Med; 2006 Jun;20(5):357-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 26-year-old woman presented to the hospital with a slowly growing abdominal tumor without symptoms.
  • Computed tomography (CT) revealed huge retroperitoneal tumors and fused 18F-fluorodeoxyglucose positron emission tomography (FDG-PET)/CT image showed abnormal accumulation of FDG in tumors with maximal standardized uptake value of 2.02.
  • However, a second primary malignant tumor, such as malignant peripheral nerve sheath tumor arising in ganglioneuroma, could not be ruled out.
  • Pathological investigation may be needed to differentiate ganglioneuroma from other malignant tumors and, therefore, FDG-PET/CT findings can be helpful for biopsy planning.
  • [MeSH-major] Abdominal Neoplasms / radionuclide imaging. Fluorodeoxyglucose F18. Neuroma / radionuclide imaging

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16878708.001).
  • [ISSN] 0914-7187
  • [Journal-full-title] Annals of nuclear medicine
  • [ISO-abbreviation] Ann Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


84. Sreeja S, Sreeja S: An in vitro study on antiproliferative and antiestrogenic effects of Boerhaavia diffusa L. extracts. J Ethnopharmacol; 2009 Nov 12;126(2):221-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • ETHNOPHARMACOLOGICAL RELEVANCE: Boerhaavia diffusa L. (Nyctinaceae) is a plant of tropical region used in Indian traditional medicine for the treatment of human ailments including abdominal tumor, jaundice, dyspepsia, menstrual disorders, etc.
  • [MeSH-major] Antineoplastic Agents, Phytogenic / therapeutic use. Breast Neoplasms / drug therapy. Cell Proliferation / drug effects. Estrogen Antagonists / therapeutic use. Nyctaginaceae. Plant Extracts / therapeutic use. Receptors, Estrogen / drug effects
  • [MeSH-minor] Cell Cycle / drug effects. Cell Line, Tumor. Estradiol / metabolism. Female. Gene Expression. Humans. Inhibitory Concentration 50. Phytotherapy. RNA, Messenger / metabolism. Tumor Suppressor Proteins / genetics. Tumor Suppressor Proteins / metabolism

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • Hazardous Substances Data Bank. ESTRADIOL .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19723573.001).
  • [ISSN] 1872-7573
  • [Journal-full-title] Journal of ethnopharmacology
  • [ISO-abbreviation] J Ethnopharmacol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Estrogen Antagonists; 0 / Plant Extracts; 0 / RNA, Messenger; 0 / Receptors, Estrogen; 0 / TFF1 protein, human; 0 / Tumor Suppressor Proteins; 4TI98Z838E / Estradiol
  •  go-up   go-down


85. Kalapurakal JA, Li SM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, Thomas PR, Grundy P, Green DM, D'Angio GJ: Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys; 2010 Jan 1;76(1):201-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group.
  • PURPOSE: We undertook this study to determine (1) the frequency with which spilled tumor cells of favorable histology produced intra-abdominal disease in patients treated with differing chemotherapy regimens and abdominal radiation therapy (RT) and (2) the patterns of relapse and outcomes in such patients.
  • METHODS AND MATERIALS: The influence of RT dose (0, 10, and 20 Gy), RT fields (flank, whole abdomen), and chemotherapy with dactinomycin and vincristine (2 drugs) vs. added doxorubicin (three drugs) on intra-abdominal tumor recurrence rates was analyzed by logistic regression in 450 patients.
  • CONCLUSIONS: Irradiation (10 Gy or 20 Gy) reduced abdominal tumor recurrence rates after tumor spillage.
  • Tumor spillage in Stage II patients reduced relapse-free survival and overall survival, but only the latter was of statistical significance.
  • These data provide a basis for assessing the risks vs. benefits when considering treatment for children with favorable histology Wilms tumor and surgical spillage.

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Wilms Tumor.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. DACTINOMYCIN .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 1998 Jan;16(1):237-45 [9440748.001]
  • [Cites] J Clin Oncol. 2008 Sep 1;26(25):4055-7 [18757319.001]
  • [Cites] Pediatr Blood Cancer. 2007 May;48(5):493-9 [16547940.001]
  • [Cites] Ann Surg. 1999 Feb;229(2):292-7 [10024113.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):203-9 [16542795.001]
  • [Cites] J Clin Oncol. 2001 Apr 1;19(7):1926-34 [11283124.001]
  • [Cites] Med Pediatr Oncol. 2001 Feb;36(2):295-304 [11452938.001]
  • [Cites] J Clin Oncol. 2002 May 15;20(10):2506-13 [12011129.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):495-9 [12957262.001]
  • [Cites] Med Pediatr Oncol. 2003 Dec;41(6):545-9 [14595712.001]
  • [Cites] Cancer. 1976 Aug;38(2):633-46 [184912.001]
  • [Cites] Cancer. 1976 Aug;38(2):647-54 [184913.001]
  • [Cites] Cancer. 1981 May 1;47(9):2302-11 [6164480.001]
  • [Cites] Cancer Clin Trials. 1981;4(2):167-71 [6265112.001]
  • [Cites] Biometrics. 1986 Mar;42(1):121-30 [3719049.001]
  • [Cites] J Clin Oncol. 1989 May;7(5):638-47 [2540289.001]
  • [Cites] Cancer. 1989 Jul 15;64(2):349-60 [2544249.001]
  • [Cites] Cancer. 1991 Oct 15;68(8):1703-7 [1655223.001]
  • [Cites] J Clin Oncol. 1995 Aug;13(8):1851-9 [7636528.001]
  • (PMID = 19395185.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA054498-13; United States / NCI NIH HHS / CA / R01 CA054498; United States / NCI NIH HHS / CA / R01 CA054498-13
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  • [Chemical-registry-number] 1CC1JFE158 / Dactinomycin; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin
  • [Other-IDs] NLM/ NIHMS167454; NLM/ PMC2843421
  •  go-up   go-down


86. Beraud R, Carozzo C: Perirenal expanding haematoma in a cat. J Small Anim Pract; 2007 Jan;48(1):43-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A four-year-old, entire male domestic cat was referred for assessment of a large abdominal mass of three-weeks duration.
  • Diagnostic imaging suggested the presence of either splenic neoplasia, an abdominal abscess or haematoma.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17212749.001).
  • [ISSN] 0022-4510
  • [Journal-full-title] The Journal of small animal practice
  • [ISO-abbreviation] J Small Anim Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


87. Cissé M, Konaté I, Ka O, Dieng M, Dia A, Touré CT: Giant splenic pseudocyst, a rare aetiology of abdominal tumor: a case report. Cases J; 2010;3:16
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant splenic pseudocyst, a rare aetiology of abdominal tumor: a case report.
  • CASE PRESENTATION: A twenty-year old Senegalese woman, was admitted with a three-month history of spontaneous abdominal mass associated with a pain.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg. 2000 Sep;180(3):227 [11084135.001]
  • [Cites] J Am Coll Surg. 2002 Mar;194(3):306-14 [11893134.001]
  • (PMID = 20148140.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2820005
  •  go-up   go-down


88. Jung B, Påhlman L, Johansson R, Nilsson E: Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995-2004. BMC Cancer; 2009;9:68
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients > or = 75 years were less likely to have distant metastases than younger patients (14.8% vs. 17.8%, P < 0.001), and underwent abdominal tumor resection less frequently (68.5% vs. 84.4%, P < 0.001).
  • Of 11,725 patients with abdominal tumor resection (anterior resection [AR], abdominoperineal excision [APE], and Hartmann's procedure [HA]), 37.4% were > or = 75 years.
  • Choice of abdominal operation differed significantly between the two age groups for both curative and non-curative surgery, The frequency of APE was similar in both age groups (29.5% vs. 28.6%), but patients > or = 75 years were more likely to have HA (16.9% vs. 4.9%) and less likely to have preoperative radiotherapy (34.3 vs. 67.2%, P < 0.001).
  • Local recurrence following surgery for low tumors and quality of life aspects deserve particular attention.
  • [MeSH-major] Rectal Neoplasms / radiotherapy. Rectal Neoplasms / surgery
  • [MeSH-minor] Age Factors. Aged. Aged, 80 and over. Combined Modality Therapy. Digestive System Surgical Procedures / methods. Female. Humans. Male. Medical Audit. Neoplasm Recurrence, Local / pathology. Neoplasm Staging. Registries. Survival Rate. Sweden


89. Saab R, Khoury JD, Krasin M, Davidoff AM, Navid F: Desmoplastic small round cell tumor in childhood: the St. Jude Children's Research Hospital experience. Pediatr Blood Cancer; 2007 Sep;49(3):274-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoplastic small round cell tumor in childhood: the St. Jude Children's Research Hospital experience.
  • BACKGROUND: Desmoplastic small round cell tumor (DSRCT) is a rare, primarily intra-abdominal tumor that has a poor outcome with current therapies.
  • PROCEDURE: We retrospectively reviewed patient characteristics, presenting symptoms, tumor pathology, treatment, and outcome of 11 pediatric patients with DSRCT at our institution.
  • In eight (73%) patients, the primary tumor was abdominal or pelvic, and in one patient each, it was submental, mediastinal, and paratesticular.
  • Nine (82%) patients had metastatic disease.
  • All tumors showed polyphenotypic differentiation by immunohistochemistry.
  • The EWS-WT1 transcript was detected in six of seven tumors tested.
  • One tumor showed rhabdomyoblastic differentiation after therapy.
  • Two died of treatment-related toxicity, six died of disease.
  • Patients with localized extra-abdominal disease have a better prognosis, most likely due to increased feasibility of resection.
  • [MeSH-major] Abdominal Neoplasms / pathology. Abdominal Neoplasms / therapy. Neoplasms, Complex and Mixed / pathology. Neoplasms, Complex and Mixed / therapy

  • Genetic Alliance. consumer health - Desmoplastic Small Round Cell Tumor.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16685737.001).
  • [ISSN] 1545-5009
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA 21765
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / EWS1-WT1 fusion protein, human; 0 / Oncogene Proteins, Fusion
  •  go-up   go-down


90. Giunti L, Bernini G, Forni M, Tucci F, Wheeler E, Sardi I: Clonality analysis of pediatric multiple tumors: two case reports and laboratory investigation. J Pediatr Hematol Oncol; 2006 Apr;28(4):241-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clonality analysis of pediatric multiple tumors: two case reports and laboratory investigation.
  • We examined the possibility of using microsatellite and mitochondrial DNA polymorphisms as markers to detect the clonal origin of tumor cells found in the same patient.
  • We considered two children with complex tumor diseases: one with supratentorial primitive neuroectodermal tumors (PNET) and a hepatic rhabdoid tumor and another with brain and abdominal rhabdoid tumors.
  • In the first patient we found an mtDNA cytosine insertion both in the normal tissue and in the primary tumor, whereas in the hepatic tumor we detected an insertion of 2 cytosine.
  • In the second child, who had a constitutional mutation of hSNF5/INI-1, we identified the same mtDNA pattern both in normal tissue and in the abdominal tumor but not in the brain tumor, which presented three different mtDNA polymorphisms.
  • Thus, we demonstrated the same clonal origin for tumors in the first patient and different clonal origins of the tumors in the second patient.
  • Molecular examination of clonality is a useful tool to obtain information about the origin of synchronous and/or metachronous tumors found in the same patient.
  • [MeSH-major] Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16679923.001).
  • [ISSN] 1077-4114
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA, Mitochondrial
  •  go-up   go-down


91. Poirot CJ, Martelli H, Genestie C, Golmard JL, Valteau-Couanet D, Helardot P, Pacquement H, Sauvat F, Tabone MD, Philippe-Chomette P, Esperou H, Baruchel A, Brugieres L: Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer. Pediatr Blood Cancer; 2007 Jul;49(1):74-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 16 cases, the ovary was harvested during laparotomy to resect a residual abdominal tumor.
  • None of the cases had visible ovarian tumor components.
  • [MeSH-major] Cryopreservation / methods. Neoplasms / drug therapy. Organ Preservation. Ovary. Reproductive Techniques, Assisted


92. Nakamura Y, Tajiri T, Uchida E, Arima Y, Aimoto T, Katsuno A, Naito Z: Changes to levels of serum neuron-specific enolase in a patient with small cell carcinoma of the pancreas. J Hepatobiliary Pancreat Surg; 2005;12(1):93-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Small cell carcinoma (SCC) of the pancreas is a rare disease, with an extremely poor prognosis; only 24 cases have been reported in the literature.
  • A 69-year-old woman presented with an abdominal tumor and pain.
  • Initially, the tumor disappeared completely on computed tomography (CT) scans, but she died of disease recurrence 3 months after completing the chemotherapy.
  • Changes in serum neuron-specific enolase (NSE) levels were monitored constantly during the progress of the disease.
  • NSE levels had already increased above the upper limit of normal 8 months before the patient's admission to our hospital, and levels changed concurrently not only with tumor growth but also subsequently with remission and then relapse of the disease after treatment.
  • [MeSH-major] Carcinoma, Small Cell / blood. Pancreatic Neoplasms / blood. Phosphopyruvate Hydratase / blood
  • [MeSH-minor] Aged. Biomarkers, Tumor / blood. Female. Humans

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15754108.001).
  • [ISSN] 0944-1166
  • [Journal-full-title] Journal of hepato-biliary-pancreatic surgery
  • [ISO-abbreviation] J Hepatobiliary Pancreat Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 4.2.1.11 / Phosphopyruvate Hydratase
  •  go-up   go-down


93. Giesel FL, Mehndiratta A, Locklin J, McAuliffe MJ, White S, Choyke PL, Knopp MV, Wood BJ, Haberkorn U, von Tengg-Kobligk H: Image fusion using CT, MRI and PET for treatment planning, navigation and follow up in percutaneous RFA. Exp Oncol; 2009 Jun;31(2):106-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIM: To evaluate the feasibility of fusion of morphologic and functional imaging modalities to facilitate treatment planning, probe placement, probe re-positioning, and early detection of residual disease following radiofrequency ablation (RFA) of cancer.
  • Different combinations of imaging modalities were registered and fused prior to, during, and following percutaneous image-guided tumor ablation with radiofrequency.
  • CONCLUSION: Fusion of morphologic and functional images is feasible before, during and after radiofrequency ablation of tumors in abdominal organs.
  • [MeSH-major] Catheter Ablation. Image Interpretation, Computer-Assisted / methods. Magnetic Resonance Imaging. Neoplasms / therapy. Positron-Emission Tomography. Therapy, Computer-Assisted / methods

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acad Radiol. 2006 Aug;13(8):986-94 [16843851.001]
  • [Cites] J Vasc Interv Radiol. 2005 Apr;16(4):493-505 [15802449.001]
  • [Cites] Ann Surg Oncol. 2008 Oct;15(10):2757-64 [18618182.001]
  • [Cites] Med Image Anal. 1998 Mar;2(1):1-36 [10638851.001]
  • [Cites] J Digit Imaging. 2000 May;13(2 Suppl 1):196-9 [10847399.001]
  • [Cites] Semin Nucl Med. 2001 Jul;31(3):191-205 [11430526.001]
  • [Cites] IEEE Trans Med Imaging. 2001 Jun;20(6):526-34 [11437112.001]
  • [Cites] Med Image Anal. 2001 Jun;5(2):143-56 [11516708.001]
  • [Cites] Cancer. 2002 Jan 15;94(2):443-51 [11900230.001]
  • [Cites] Ann Thorac Surg. 2002 Jul;74(1):160-3; discussion 163 [12118750.001]
  • [Cites] J Nucl Med. 2002 Sep;43(9):1129-36 [12215549.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):32-9 [12483407.001]
  • [Cites] Radiology. 2003 Feb;226(2):417-24 [12563135.001]
  • [Cites] Eur Radiol. 2003 Apr;13(4):734-9 [12664111.001]
  • [Cites] Comput Aided Surg. 2002;7(6):317-25 [12731094.001]
  • [Cites] Semin Nucl Med. 2003 Jul;33(3):205-18 [12931322.001]
  • [Cites] Med Phys. 2003 Oct;30(10):2762-92 [14596315.001]
  • [Cites] J Clin Oncol. 2004 Jan 15;22(2):300-6 [14722039.001]
  • [Cites] J Nucl Med. 2004 Jan;45 Suppl 1:4S-14S [14736831.001]
  • [Cites] J Nucl Med. 2004 Mar;45(3):357-65 [15001674.001]
  • [Cites] Radiology. 2004 Apr;231(1):65-72 [14990824.001]
  • [Cites] Eur Radiol. 2004 May;14(5):897-901 [14666377.001]
  • [Cites] Eur J Med Res. 2004 May 28;9(5):241-6 [15257877.001]
  • [Cites] Cancer J. 2004 Jul-Aug;10(4):221-33 [15383203.001]
  • [Cites] Radiology. 1988 Dec;169(3):860-1 [3263667.001]
  • [Cites] Radiology. 1989 Sep;172(3):861-5 [2788895.001]
  • [Cites] J Nucl Med. 1990 Jul;31(7):1227-9 [2362202.001]
  • [Cites] J Nucl Med. 1993 Jul;34(7):1190-7 [8315501.001]
  • [Cites] J Nucl Med. 1993 Sep;34(9):1587-94 [8355080.001]
  • [Cites] J Nucl Med. 1994 Dec;35(12):2011-8 [7989986.001]
  • [Cites] Semin Nucl Med. 1994 Oct;24(4):256-71 [7817199.001]
  • [Cites] Cancer Res. 1995 Dec 1;55(23 Suppl):5759s-5763s [7493342.001]
  • [Cites] Nucl Med Biol. 1994 Jul;21(5):775-84 [9241654.001]
  • [Cites] Biophys Chem. 1997 Oct;68(1-3):207-19 [9468620.001]
  • [Cites] Med Image Anal. 1997 Apr;1(3):195-206 [9873906.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):883-91 [10098445.001]
  • [Cites] Am J Surg. 1999 Apr;177(4):303-6 [10326848.001]
  • [Cites] Med Image Comput Comput Assist Interv. 2007;10(Pt 2):969-77 [18044662.001]
  • (PMID = 19550401.001).
  • [ISSN] 1812-9269
  • [Journal-full-title] Experimental oncology
  • [ISO-abbreviation] Exp. Oncol.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 BC010714-03
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] Ukraine
  • [Other-IDs] NLM/ NIHMS188708; NLM/ PMC2850071
  •  go-up   go-down


94. Fujishima N, Fujishima M, Inomata M, Yamanaka Y, Saitoh K, Kameoka Y, Yoshioka T, Saitoh H, Takahashi N, Hirokawa M, Sawada K: [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy]. Rinsho Ketsueki; 2007 Apr;48(4):326-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 43-year-old female was admitted with therapy-resistant pancreatitis and an abdominal tumor around the pancreatic head.
  • Although CODOX-M and IVAC therapy combined with rituximab achieved complete remission, she died of rapid progressive disease during whole brain irradiation before autologous peripheral blood stem cell transplantation.
  • A more effective therapy remains to be established for the treatment of this disease.
  • [MeSH-minor] Adult. Antibodies, Monoclonal / administration & dosage. Antibodies, Monoclonal, Murine-Derived. Cyclophosphamide / administration & dosage. Cytarabine / administration & dosage. Disease Progression. Doxorubicin / administration & dosage. Etoposide / administration & dosage. Fatal Outcome. Female. Humans. Ifosfamide / administration & dosage. Methotrexate / administration & dosage. Recurrence. Remission Induction. Rituximab. Vincristine / administration & dosage

  • Genetic Alliance. consumer health - Burkitt's Lymphoma.
  • Hazardous Substances Data Bank. CYTARABINE .
  • Hazardous Substances Data Bank. RITUXIMAB .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • Hazardous Substances Data Bank. METHOTREXATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17515125.001).
  • [ISSN] 0485-1439
  • [Journal-full-title] [Rinshō ketsueki] The Japanese journal of clinical hematology
  • [ISO-abbreviation] Rinsho Ketsueki
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 04079A1RDZ / Cytarabine; 4F4X42SYQ6 / Rituximab; 5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; UM20QQM95Y / Ifosfamide; YL5FZ2Y5U1 / Methotrexate; ANAVACYM protocol; IVAC protocol
  •  go-up   go-down


95. Csak T, Folhoffer A, Horvath A, Halász J, Diczházi C, Schaff Z, Szalay F: Holmes-Adie syndrome, autoimmune hepatitis and celiac disease: a case report. World J Gastroenterol; 2006 Mar 7;12(9):1485-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Holmes-Adie syndrome, autoimmune hepatitis and celiac disease: a case report.
  • No tumor or other neurological abnormality was found.
  • Abdominal tumor was detected by ultrasound.
  • The surgically removed tumor was histologically a benign mesenteric multicystic lymphangioma.Simultaneously, celiac disease was diagnosed.Gluten-free diet resulted in a significant improvement of celiac disease,but not of autoimmune hepatitis.
  • The patient was a homozygous carrier for HLA DQ2 antigen characteristic for celiac disease and heterozygous for HLA DR3 B8 frequent in autoimmune liver diseases.
  • Our novel observation on association of Holmes-Adie syndrome with autoimmune hepatitis and celiac disease is suggestive for a common immunological background for all three entities present in a patient with mesenteric multicystic lymphangioma.
  • [MeSH-major] Adie Syndrome / complications. Celiac Disease / complications. Hepatitis, Autoimmune / complications
  • [MeSH-minor] Adult. Female. Humans. Lymphangioma, Cystic / complications. Lymphangioma, Cystic / diagnosis. Peritoneal Neoplasms / complications. Peritoneal Neoplasms / diagnosis


96. Saito F, Okabe Y, Suga H, Watanabe T, Arinaga T, Naito Y, Uchida S, Hisaka T, Toyonaga A, Kojiro M, Kinoshita H, Tsuruta O, Sata M: [A case of hepatic eosinophilic granuloma, which needs distinction with metastatic liver cancer]. Nihon Shokakibyo Gakkai Zasshi; 2008 Oct;105(10):1509-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 68-year-old man was referred to our hospital because of eosinophilia in peripheral blood and pancreatic tumor on abdominal US.
  • Pancreatic tumor was diagnosed to the pancreatic ductal cancer by the imaging examination and endoscopic transpapillary brushing cytology for pancreatic duct.
  • Because of the strong positive finding for nematose in the assay of multi dot-ELISA for parasite, hepatic eosinophilic granuloma caused by visceral larva migrans was accidentally complicated by pancreatic cancer, and operation for the pancreatic cancer was done.
  • To bear this disease in mind and to research his life history, is important to diagnose hepatic multiple nodules with eosinophilia.
  • [MeSH-major] Eosinophilic Granuloma / diagnosis. Liver Diseases / diagnosis. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Larva Migrans / complications. Male. Pancreatic Neoplasms / complications


97. Tica VI, Beghim M, Beghim E, Dehelean I, Zaher M, Tica I: [Urachal cyst in an adult woman]. Chirurgia (Bucur); 2007 Mar-Apr;102(2):227-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Chist voluminos de uracă la o femeie adultă.
  • We report a case of urachal cyst in an adult woman in whom it was difficult to determine preoperatively the origin of the abdominal tumor.
  • Even rare, this pathology should be considered in the differential diagnosis of an abdominal cyst.

  • Genetic Alliance. consumer health - Urachal cyst.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17615928.001).
  • [ISSN] 1221-9118
  • [Journal-full-title] Chirurgia (Bucharest, Romania : 1990)
  • [ISO-abbreviation] Chirurgia (Bucur)
  • [Language] rum
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


98. Boithias C, Martelli H, Destot-Vong KD, Dugelay F, Branchereau S, Fabre M, Senat MV, Boileau P, Frydman R, Picone O: [Management of antenatal fetal abdominal tumors. Clues for the diagnosis of a congenital mesoblastic nephroma]. J Gynecol Obstet Biol Reprod (Paris); 2009 Jun;38(4):277-85
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Management of antenatal fetal abdominal tumors. Clues for the diagnosis of a congenital mesoblastic nephroma].
  • The prenatal diagnosis of abdominal mass poses the problem of its origin.
  • Renal tumors are rarer than neuroblastoma but they are most often congenital mesoblastic nephroma.
  • MRI can help to locate tumor but cannot tell difference between the different kinds of renal tumor.
  • Histolological study of the tumor is important for the prognosis.
  • The diagnosis of the tumor does not change the mode of delivery except in case of an important volume.
  • [MeSH-major] Kidney Neoplasms / ultrasonography. Nephroma, Mesoblastic / ultrasonography
  • [MeSH-minor] Abdomen / embryology. Abdomen / ultrasonography. Diagnosis, Differential. Female. Humans. Infant. Infant, Newborn. Pregnancy. Pregnancy Trimester, Third. Treatment Outcome

  • Genetic Alliance. consumer health - Congenital Mesoblastic Nephroma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19386447.001).
  • [ISSN] 0368-2315
  • [Journal-full-title] Journal de gynécologie, obstétrique et biologie de la reproduction
  • [ISO-abbreviation] J Gynecol Obstet Biol Reprod (Paris)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


99. Mizutani S, Nakamura Y, Ogata M, Watanabe M, Tokunaga A, Tajiri T: A case of giant mucinous cystic neoplasm of the pancreas resected with laparoscopic surgery. J Nippon Med Sch; 2009 Aug;76(4):212-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of giant mucinous cystic neoplasm of the pancreas resected with laparoscopic surgery.
  • We report a case of giant mucinous cystic neoplasm (MCN) of the pancreas that was successfully treated with laparoscopic surgery.
  • A 29-year-old woman was admitted to our hospital for evaluation of an abdominal tumor that had been detected during a routine medical examination.
  • The tumor was diagnosed as an MCN of the pancreas.
  • [MeSH-major] Cystadenoma, Mucinous / surgery. Laparoscopy. Pancreatectomy / methods. Pancreatic Neoplasms / surgery. Splenectomy / methods

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19755797.001).
  • [ISSN] 1345-4676
  • [Journal-full-title] Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
  • [ISO-abbreviation] J Nippon Med Sch
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


100. Cai J, Read PW, Sheng K: The effect of respiratory motion variability and tumor size on the accuracy of average intensity projection from four-dimensional computed tomography: an investigation based on dynamic MRI. Med Phys; 2008 Nov;35(11):4974-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effect of respiratory motion variability and tumor size on the accuracy of average intensity projection from four-dimensional computed tomography: an investigation based on dynamic MRI.
  • Composite images such as average intensity projection (AIP) and maximum intensity projection (MIP) derived from four-dimensional computed tomography (4D-CT) images are commonly used in radiation therapy for treating lung and abdominal tumors.
  • Subsequently, the resultant MIP underestimates the actual tumor motion extent.
  • As a more general application, AIP comprises not only the tumor motion extent but also the probability that the tumor is present.
  • Five-minute MRI scans were performed on seven healthy volunteers and eight lung tumor patients.
  • In addition, images of circular phantoms with diameter 1, 3, or 5 cm were generated by software to simulate lung tumors.
  • AIP similarity indicated by the Dice index between RedCAM and dMRI was calculated and correlated with respiratory variability (v) and tumor size (s).
  • The similarity of percentile intrafractional motion target area (IMTA), defined by the area that the tumor presented for a given percentage of time, and MIP-to-percentile IMTA similarity as a function of percentile were also determined.
  • As a result, AIP similarity depends on both respiratory variability and tumor sizes.
  • The AIP similarity correlated linearly with the respiratory variability normalized by tumor sizes (R2 equal to 0.82 and 0.91 for the phantom study and the patient study, respectively).
  • For both studies, MIP derived from RedCAM was close to the area that the tumor presented 90% or more of the time and missed the region where the tumor appeared less than 10% of the time.
  • In conclusion, the accuracy of composite images such as AIP and MIP derived from 4D-CT to define the tumor motion and position is affected by patient-specific respiratory variability and tumor sizes.
  • [MeSH-major] Artifacts. Image Processing, Computer-Assisted / methods. Lung Neoplasms / diagnostic imaging. Magnetic Resonance Imaging / methods. Movement. Respiration. Tomography, X-Ray Computed / methods






Advertisement